PRAGMA foreign_keys=OFF;
BEGIN TRANSACTION;
CREATE TABLE biomarker_dictionary (
	id INTEGER NOT NULL, 
	standard_name VARCHAR, 
	alternate_names TEXT, 
	standard_unit VARCHAR, 
	unit_conversions TEXT, 
	category VARCHAR, 
	reference_ranges TEXT, 
	description TEXT, 
	created_date DATETIME, 
	updated_date DATETIME, 
	PRIMARY KEY (id)
);
INSERT INTO biomarker_dictionary VALUES(1,'Fasting Blood Sugar','[]','mg/dL','{}',NULL,'{}','Fasting Blood Sugar, also known as Fasting Plasma Glucose (FPG), is a blood test that measures the amount of glucose (sugar) in your blood after you have not eaten for at least 8 hours. Glucose is the main source of energy for the body''s cells, and it''s important to maintain healthy blood sugar levels. This test is used to screen for prediabetes and diabetes, which are conditions where the body has trouble regulating blood sugar.','2025-04-01 12:45:37.324671','2025-04-01 12:45:37.324682');
INSERT INTO biomarker_dictionary VALUES(2,'Total Cholesterol','[]','mg/dL','{}',NULL,'{}','Total cholesterol is a measurement of the overall amount of cholesterol in your blood. Cholesterol is a waxy, fat-like substance that is essential for many bodily functions, but can also contribute to the buildup of plaque in your arteries if levels get too high. High total cholesterol levels are a major risk factor for heart disease and stroke, so it''s an important biomarker to monitor.','2025-04-02 14:45:34.660205','2025-04-02 14:45:34.660207');
INSERT INTO biomarker_dictionary VALUES(3,'Albumin/Globulin Ratio','[]','Ratio','{}',NULL,'{}',replace('The albumin/globulin (A/G) ratio is a measure that compares the levels of two main types of proteins in your blood: albumin and globulins. Albumin is a protein made by your liver that helps maintain fluid balance in your body. Globulins are a group of proteins that play important roles in immune function and blood clotting.\n\nThe A/G ratio provides insight into the balance between these two protein groups. It can give your healthcare provider information about your overall health, liver function, and certain medical conditions. An abnormal A/G ratio may indicate an underlying issue, such as liver disease, inflammation, or an immune system disorder.','\n',char(10)),'2025-04-02 20:20:39.876428','2025-04-02 20:20:39.876438');
CREATE TABLE profiles (
	id CHAR(32) NOT NULL, 
	name VARCHAR NOT NULL, 
	date_of_birth DATETIME, 
	gender VARCHAR, 
	patient_id VARCHAR, 
	created_at DATETIME, 
	last_modified DATETIME, favorite_biomarkers JSON DEFAULT '[]', health_summary TEXT, summary_last_updated DATETIME, user_id VARCHAR(36), 
	PRIMARY KEY (id)
);
INSERT INTO profiles VALUES('3edc5fb9c2fa48b2a66a2be1b8c7f9d4','ANKIT','1985-10-03 00:00:00.000000','male','ANKIM504584650','2025-04-01 11:37:08.673525','2025-04-03 16:14:47.273620','[]',NULL,NULL,'fa9800f4-3cf6-402b-aa14-2adfbdac91d4');
INSERT INTO profiles VALUES('6943fda865cf4031806a4e03190d18e4','SANDHYA SINHA','1959-04-29 00:00:00.000000','female','SANDF260260706','2025-04-01 12:08:04.483941','2025-04-03 16:14:47.273655','[]',NULL,NULL,'fa9800f4-3cf6-402b-aa14-2adfbdac91d4');
INSERT INTO profiles VALUES('212c0a9391fc4fde9be25eca648133ab','Mr. Aman Ankur','1991-11-11 00:00:00.000000','male','OHP2U87Z155060','2025-04-01 17:37:21.900023','2025-04-04 04:36:40.511671','["HDL Cholesterol", "LDL Cholesterol", "Triglycerides", "Glucose", "Vitamin B12", "Vitamin D", "Free Testosterone", "Average Blood Glucose"]',replace('üí° KEY INSIGHTS:\n\n‚Ä¢ Your LDL cholesterol (177.0 mg/dL) and triglycerides (232.0 mg/dL) are significantly elevated, increasing your risk for heart disease and stroke. Healthy levels are <100 mg/dL and <150 mg/dL, respectively.\n\n‚Ä¢ Your non-HDL cholesterol (211.1 mg/dL) is alarmingly high, indicating a higher risk for heart attacks and strokes. The ideal level is <160 mg/dL.\n\n‚Ä¢ Your LDL/HDL ratio (4.7) and triglyceride/HDL ratio (6.21) are unfavorable, signaling a potential imbalance in your cholesterol levels and increased cardiovascular risk.\n\n‚Ä¢ Your eosinophil counts (7.6% and 0.75 10^3/¬µL) are elevated, suggesting an active allergic response or inflammatory condition that needs further evaluation.\n\n‚Ä¢ Your VLDL cholesterol (46.46 mg/dL) is higher than recommended (<40 mg/dL), indicating increased levels of very-low-density lipoproteins, which can contribute to plaque buildup in arteries.\n\nüìà POSITIVE DEVELOPMENTS:\n\n‚Ä¢ Your HDL cholesterol has improved from 30.0 mg/dL to 37.0 mg/dL, a 23.3% increase, although it remains slightly below the optimal range of 40-60 mg/dL.\n\n‚Ä¢ Your LDL/HDL ratio has decreased from 5.0 to 4.7, a 6.0% improvement, moving closer to the recommended range of 1.5-3.5.\n\nüëÄ AREAS TO MONITOR:\n\n‚Ä¢ Your direct bilirubin level was abnormally high in a previous measurement, which could indicate liver or gallbladder issues. Monitor this closely.\n\n‚Ä¢ Your glucose levels (95.0 mg/dL and 105.0 mg/dL) are within the acceptable range but on the higher end, suggesting potential insulin resistance or prediabetes. Monitor glucose levels and consider lifestyle changes.\n\n‚Ä¢ Your Vitamin D level (40.45 ng/mL) is insufficient, which can impact bone health, immune function, and potentially increase cardiovascular risk. Consider supplementation or increasing sun exposure.\n\nOverall, your lipid profile and cholesterol ratios are the most concerning areas, indicating an increased risk for heart disease and stroke. Addressing these through dietary changes, exercise, and potentially medication is crucial. Regular monitoring and follow-up with your healthcare provider are recommended.','\n',char(10)),'2025-04-03 10:47:28.625725','fa9800f4-3cf6-402b-aa14-2adfbdac91d4');
INSERT INTO profiles VALUES('79cc25a835c24aa7a3d261f43d682249','User One','1990-01-01 00:00:00.000000','male','USER1_ID','2025-04-03 16:33:40.580193','2025-04-03 16:33:40.580193','[]',NULL,NULL,'user_1');
CREATE TABLE pdfs (
	id INTEGER NOT NULL, 
	file_id VARCHAR, 
	filename VARCHAR, 
	file_path VARCHAR, 
	upload_date DATETIME, 
	processed_date DATETIME, 
	report_date DATETIME, 
	extracted_text TEXT, 
	status VARCHAR, 
	error_message TEXT, 
	profile_id CHAR(32), 
	lab_name VARCHAR, 
	patient_name VARCHAR, 
	patient_id VARCHAR, 
	patient_age INTEGER, 
	patient_gender VARCHAR, 
	processing_details JSON, 
	parsing_confidence FLOAT, 
	PRIMARY KEY (id), 
	FOREIGN KEY(profile_id) REFERENCES profiles (id)
);
INSERT INTO pdfs VALUES(1,'676af6b461a6479a172440d1c1693398ab29876891c92192be83a8f5634cf5e5','agilus_report.pdf','uploads/45586a62-3d73-45f7-972f-815972f6d47c-agilus_report.pdf','2025-04-01 11:57:29.654120','2025-04-01 11:58:24.313783','2025-01-30 00:00:00.000000',replace('MC-6515DIAGNOSTIC REPORT\nGRSANKALP,D-415 PATIENT NAME :  ANKITPATIENT ID       :ANKIM504584650ACCESSION NO :0278YA001822AGE/SEX    :37 YearsMaleABHA NO          :DRAWN      :30/01/2025 10:30:00RECEIVED  :30/01/2025 12:12:31REPORTED  :30/01/2025 16:05:04REF. DOCTOR : SELFCLIENT PATIENT ID: ANKIM504584650ANKIT  560099\nFinalResultsBiological Reference IntervalTest Report StatusUnits\nHAEMATOLOGY - CBCCOMPLETE CARE  ACTIVE MENBLOOD COUNTS, EDTA WHOLE BLOODHEMOGLOBIN(HB)15.013.0 - 17.0g/dLMETHOD : SLS METHODREDBLOODCELL(RBC)COUNT5.284.5 - 5.5mil/¬µLMETHOD : AUTOMATED CELL COUNTER:HYDRO DYNAMIC FOUSING (DC DETECTION)WHITEBLOODCELL(WBC)COUNT9.234.0 - 10.0thou/¬µLMETHOD : FLOW CYTOMETRY/MANUAL MICROSCOPYPLATELETCOUNT348150 - 410thou/¬µLMETHOD : AUTOMATED CELL COUNTER:HYDRO DYNAMIC FOUSING (DC DETECTION)RBC AND PLATELET INDICESHEMATOCRIT(PCV)45.040 - 50%METHOD : AUTOMATED CELL COUNTER :PULSE HEIGHT DETECTIONMEANCORPUSCULARVOLUME(MCV)85.283.0 - 101.0fLMETHOD : CALCULATED PARAMETERMEANCORPUSCULARHEMOGLOBIN(MCH)28.427.0 - 32.0pgMEANCORPUSCULARHEMOGLOBINCONCENTRATION(MCHC)33.331.5 - 34.5g/dLMETHOD : AUTOMATED CELL COUNTER : CALCULATED PARAMETERREDCELLDISTRIBUTIONWIDTH(RDW)13.811.6 - 14.0%METHOD : AUTOMATED CELL COUNTER : CALCULATED PARAMETERMEANPLATELETVOLUME(MPV)9.66.8 - 10.9fLMETHOD : AUTOMATED CELL COUNTER : CALCULATED PARAMETERWBC DIFFERENTIAL COUNTNEUTROPHILS6440 - 80%METHOD : FLOW CYTOMETRY/MANUAL MICROSCOPYLYMPHOCYTES2620 - 40%METHOD : FLOW CYTOMETRY/MANUAL MICROSCOPYMONOCYTES72 - 10%METHOD : FLOW CYTOMETRY/MANUAL MICROSCOPYEOSINOPHILS31 - 6%\nView DetailsView ReportPage 1 Of 18\nDr.Suneet Kaur HoraLAB HEAD & Sr. CONSULTANTPATHOLOGISTULR No.775000010990001-0081AgilusDiagnosticsLtd154/9,BannerghattaRoad,Opp.Iim-B,Bangalore,560076Karnataka,IndiaTel:80-66214444,Fax: CIN-U74899PB1995PLC045956PERFORMED AT :MC-6515DIAGNOSTIC REPORT\nGRSANKALP,D-415 PATIENT NAME :  ANKITPATIENT ID       :ANKIM504584650ACCESSION NO :0278YA001822AGE/SEX    :37 YearsMaleABHA NO          :DRAWN      :30/01/2025 10:30:00RECEIVED  :30/01/2025 12:12:31REPORTED  :30/01/2025 16:05:04REF. DOCTOR : SELFCLIENT PATIENT ID: ANKIM504584650ANKIT  560099\nFinalResultsBiological Reference IntervalTest Report StatusUnitsMETHOD : FLOW CYTOMETRY/MANUAL MICROSCOPYBASOPHILS0< 1 - 2%METHOD : FLOW CYTOMETRY/MANUAL MICROSCOPYABSOLUTENEUTROPHILCOUNT5.912.0 - 7.0thou/¬µLMETHOD : FLOW CYTOMETRY METHOD / MICROSCOPYABSOLUTELYMPHOCYTECOUNT2.401.0 - 3.0thou/¬µLMETHOD : FLOW CYTOMETRY METHOD / MICROSCOPYABSOLUTEMONOCYTECOUNT0.650.2 - 1.0thou/¬µLMETHOD : FLOW CYTOMETRY METHOD / MICROSCOPYABSOLUTEEOSINOPHILCOUNT0.280.02 - 0.50thou/¬µLMETHOD : FLOW CYTOMETRY METHOD / MICROSCOPYABSOLUTEBASOPHILCOUNT0.000.0 - 0.1thou/¬µLMETHOD : FLOW CYTOMETRY METHOD / MICROSCOPY\nInterpretation(s)RBCANDPLATELETINDICES-Mentzerindex(MCV/RBC)isanautomatedcell-counterbasedcalculatedscreentooltodifferentiatecasesofIrondeficiencyanaemia(>13)fromBetathalassaemiatrait(<13)inpatientswithmicrocyticanaemia.Thisneedstobeinterpretedinlinewithclinicalcorrelationandsuspicion.EstimationofHbA2remainsthegoldstandardfordiagnosingacaseofbetathalassaemiatrait.WBCDIFFERENTIALCOUNT-Theoptimalthresholdof3.3forNLRshowedaprognosticpossibilityofclinicalsymptomstochangefrommildtosevereinCOVIDpositivepatients.Whenage=49.5yearsoldandNLR=3.3,46.1%COVID-19patientswithmilddiseasemightbecomesevere.Bycontrast,whenage<49.5yearsoldandNLR<3.3,COVID-19patientstendtoshowmilddisease.(Referenceto- ThediagnosticandpredictiveroleofNLR,d-NLRandPLRinCOVID-19patients  A.-P.Yang,etal. InternationalImmunopharmacology84(2020)106504ThisratioelementisacalculatedparameterandoutofNABLscope.\nView DetailsView ReportPage 2 Of 18\nDr.Suneet Kaur HoraLAB HEAD & Sr. CONSULTANTPATHOLOGISTULR No.775000010990001-0081AgilusDiagnosticsLtd154/9,BannerghattaRoad,Opp.Iim-B,Bangalore,560076Karnataka,IndiaTel:80-66214444,Fax: CIN-U74899PB1995PLC045956PERFORMED AT :MC-6515DIAGNOSTIC REPORT\nGRSANKALP,D-415 PATIENT NAME :  ANKITPATIENT ID       :ANKIM504584650ACCESSION NO :0278YA001822AGE/SEX    :37 YearsMaleABHA NO          :DRAWN      :30/01/2025 10:30:00RECEIVED  :30/01/2025 12:12:31REPORTED  :30/01/2025 16:05:04REF. DOCTOR : SELFCLIENT PATIENT ID: ANKIM504584650ANKIT  560099\nFinalResultsBiological Reference IntervalTest Report StatusUnits\nHAEMATOLOGYCOMPLETE CARE  ACTIVE MENGLYCOSYLATED HEMOGLOBIN(HBA1C), EDTA WHOLEBLOODHBA1C5.6Non-diabetic Adult < 5.7Pre-diabetes 5.7 - 6.4Diabetes diagnosis: > or = 6.5Therapeutic goals: < 7.0Action suggested : > 8.0(ADA Guideline 2021)%\nMETHOD : HPLCESTIMATEDAVERAGEGLUCOSE(EAG)114.0< 116.0mg/dL\nInterpretation(s)GLYCOSYLATEDHEMOGLOBIN(HBA1C),EDTAWHOLEBLOOD-UsedFor:1.Evaluatingthelong-termcontrolofbloodglucoseconcentrationsindiabeticpatients.2.Diagnosing diabetes.3.Identifying patientsatincreasedriskfordiabetes(prediabetes). TheADArecommends measurementofHbA1c(typically3-4timesperyearfortype1andpoorlycontrolled type2diabeticpatients,and2timesperyearforwell-controlled type2diabeticpatients)todeterminewhetherapatientsmetabolic controlhasremained continuously withinthetargetrange.1.eAG(Estimatedaverageglucose)convertspercentageHbA1ctomd/dl,tocomparebloodglucoselevels.2. eAGgivesanevaluationofbloodglucoselevelsforthelastcoupleofmonths.3.eAGiscalculatedaseAG(mg/dl)=28.7*HbA1c-46.7HbA1cEstimationcangetaffecteddueto:1.ShortenedErythrocytesurvival:Anyconditionthatshortenserythrocytesurvivalordecreasesmeanerythrocyteage(e.g.recoveryfromacutebloodloss,hemolyticanemia)willfalselylowerHbA1ctestresults.Fructosamineisrecommendedinthesepatientswhichindicatesdiabetescontrolover15days.2.VitaminC&Earereportedtofalselylowertestresults.(possiblybyinhibitingglycationofhemoglobin.3.Irondeficiencyanemiaisreportedtoincreasetestresults.Hypertriglyceridemia,uremia,hyperbilirubinemia,chronicalcoholism,chronicingestionofsalicylates&opiatesaddictionarereportedtointerferewithsomeassaymethods,falselyincreasingresults.4.InterferenceofhemoglobinopathiesinHbA1cestimationisseenina)Homozygoushemoglobinopathy.FructosamineisrecommendedfortestingofHbA1c.b)Heterozygousstatedetected(D10iscorrectedforHbS&HbCtrait.)c)HbF>25%onalternatepaltform(Boronateaffinitychromatography)isrecommendedfortestingofHbA1c.AbnormalHemoglobinelectrophoresis(HPLCmethod)isrecommendedfordetectingahemoglobinopathy\nView DetailsView ReportPage 3 Of 18\nDr.Suneet Kaur HoraLAB HEAD & Sr. CONSULTANTPATHOLOGISTULR No.775000010990001-0081AgilusDiagnosticsLtd154/9,BannerghattaRoad,Opp.Iim-B,Bangalore,560076Karnataka,IndiaTel:80-66214444,Fax: CIN-U74899PB1995PLC045956PERFORMED AT :MC-6515DIAGNOSTIC REPORT\nGRSANKALP,D-415 PATIENT NAME :  ANKITPATIENT ID       :ANKIM504584650ACCESSION NO :0278YA001822AGE/SEX    :37 YearsMaleABHA NO          :DRAWN      :30/01/2025 10:30:00RECEIVED  :30/01/2025 12:12:31REPORTED  :30/01/2025 16:05:04REF. DOCTOR : SELFCLIENT PATIENT ID: ANKIM504584650ANKIT  560099\nFinalResultsBiological Reference IntervalTest Report StatusUnits\nBIOCHEMISTRYCOMPLETE CARE  ACTIVE MENGLUCOSE FASTING,FLUORIDE PLASMAFBS(FASTINGBLOODSUGAR)95(Normal <100,Impaired fastingglucose:100 to 125,Diabetesmellitus:>=126(on more than1 occasion)(ADA guidelines2024)mg/dLMETHOD : HEXOKINASELIVER FUNCTION PROFILE, SERUMBILIRUBIN,TOTAL0.49Upto 1.2mg/dLMETHOD : DIAZO COLORIMETRICBILIRUBIN,DIRECT0.25< or = 0.3mg/dLMETHOD : COLORIMETRIC DIAZO METHODBILIRUBIN,INDIRECT0.240.1 - 1.0mg/dLMETHOD : CALCULATED PARAMETERTOTALPROTEIN6.76.0 - 8.0g/dLMETHOD : BIURET, END POINTALBUMIN4.43.97 - 4.94g/dLMETHOD : BROMOCRESOL GREEN (BCG)DYE BINDINGGLOBULIN2.32.0 - 3.5g/dLMETHOD : CALCULATED PARAMETERALBUMIN/GLOBULINRATIO1.91.0 - 2.1RATIOMETHOD : CALCULATED PARAMETERASPARTATEAMINOTRANSFERASE(AST/SGOT)19< OR = 50U/LMETHOD : SPECTROPHOTOMETRY, WITH PYRIDOXAL PHOSPHATE ACTIVATION-IFCCALANINEAMINOTRANSFERASE(ALT/SGPT)34< OR = 50U/LMETHOD : SPECTROPHOTOMETRY, WITH PYRIDOXAL PHOSPHATE ACTIVATION-IFCCALKALINEPHOSPHATASE12940 - 129U/LMETHOD : PNPP, AMP BUFFER-IFCCGAMMAGLUTAMYLTRANSFERASE(GGT)290 - 60U/LMETHOD : G-GLUTAMYL-CARBOXY-NITROANILIDELACTATEDEHYDROGENASE141125 - 220U/LMETHOD : SPECTROPHOTOMETRY, LACTATE TO PYRUVATE - UV-IFCC\nView DetailsView ReportPage 4 Of 18\nDr.Suneet Kaur HoraLAB HEAD & Sr. CONSULTANTPATHOLOGISTULR No.775000010990001-0081AgilusDiagnosticsLtd154/9,BannerghattaRoad,Opp.Iim-B,Bangalore,560076Karnataka,IndiaTel:80-66214444,Fax: CIN-U74899PB1995PLC045956PERFORMED AT :MC-6515DIAGNOSTIC REPORT\nGRSANKALP,D-415 PATIENT NAME :  ANKITPATIENT ID       :ANKIM504584650ACCESSION NO :0278YA001822AGE/SEX    :37 YearsMaleABHA NO          :DRAWN      :30/01/2025 10:30:00RECEIVED  :30/01/2025 12:12:31REPORTED  :30/01/2025 16:05:04REF. DOCTOR : SELFCLIENT PATIENT ID: ANKIM504584650ANKIT  560099\nFinalResultsBiological Reference IntervalTest Report StatusUnitsPHOSPHORUS, SERUMPHOSPHORUS3.12.5 - 4.5mg/dLMETHOD : SPECTROPHOTOMETRY, MOLYBDATE UV METHODMAGNESIUM, SERUMMAGNESIUM,SERUM2.31.6 - 2.6mg/dLMETHOD : XYLIDYL BLUE\nView DetailsView ReportPage 5 Of 18\nDr.Suneet Kaur HoraLAB HEAD & Sr. CONSULTANTPATHOLOGISTULR No.775000010990001-0081AgilusDiagnosticsLtd154/9,BannerghattaRoad,Opp.Iim-B,Bangalore,560076Karnataka,IndiaTel:80-66214444,Fax: CIN-U74899PB1995PLC045956PERFORMED AT :','\n',char(10)),'processed',NULL,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Agilus Diagnostics Ltd','ANKIT','ANKIM504584650',37,'Male',NULL,1.0);
INSERT INTO pdfs VALUES(2,'0c04a68ae60cc6ce46a41d1f9c6b83bcec941ac5f24c072cc6981d4e0d6916eb','Aman_freeT_march_2025.pdf','uploads/997e931d-f482-4ec8-a2af-266ec4bd7911-Aman_freeT_march_2025.pdf','2025-04-01 12:00:01.043385','2025-04-01 12:00:07.024378','2025-03-08 00:00:00.000000',replace('IMMUNOLOGY\n¬†¬†\nTestosterone - Free \nSerum\n,\nELISA\n13.01\npg/mL\n5.01-27.78\nOnly 1 \n‚Äì 2% \nof testosterone in circulation is not bound to any protein and is biologically active \n‚Äì \nthis is referred to as \n‚Äò\nfree testosterone\n‚Äô \n(FT).\nMeasurement of FT can be considered useful in the diagnosis of several conditions including androgen deficiency in \nmen and androgen excess in women. Assessment of free testosterone levels may prove beneficial and may avoid an \nincorrect diagnosis of hypogonadism in cases when low concentrations of total testosterone are determined and \nalterations of SHBG are suspected.\n-- End of Report --\nPage \n1\n / \n1\nDr. Akshay Prashantkumar \nVadavadgi\nMD Pathologist\nTest\nResults\nUnits\nBiological Reference Interval\nOHP46D3D1252442 \nPatient ID\n:\nMr. Mr Aman Ankur\nName\n:\nVisit No.\n:\nNR8765401\nReported On\n08/03/2025 09:08 PM\n:\nCollected On\n07/03/2025 08:07 AM\nReceived On\n:\n07/03/2025 11:57 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n33 Year(s) / Male\nRef. Doctor\n:\n','\n',char(10)),'processed',NULL,'212c0a9391fc4fde9be25eca648133ab',NULL,'Mr Aman Ankur','OHP46D3D1252442',33,'Male',NULL,1.0);
INSERT INTO pdfs VALUES(3,'ac6bfc35cdd8237dc60e8c8e1f15919c9dfc450acab17f5b278084fc16dfa923','sandhya_report1.pdf','uploads/01f27ce1-ad4c-4845-b67b-9e967573c538-sandhya_report1.pdf','2025-04-01 12:05:37.376609',NULL,NULL,NULL,'processing',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT INTO pdfs VALUES(4,'9c12138a0bdb894d8f9f345f7c8dae4d2fcbb76de61a18851566ef5e683de2e4','sandhya_report1.pdf','uploads/edda0be5-25f3-4902-9fb2-b3bbf6992dd4-sandhya_report1.pdf','2025-04-01 12:23:48.955032','2025-04-01 12:24:01.680590','2025-03-03 00:00:00.000000',replace('MC-2764DIAGNOSTIC REPORT\nSADARHOSPITAL, PATIENT NAME :  SANDHYA SINHAPATIENT ID       :SANDF260260706ACCESSION NO :0706YC000357AGE/SEX    :66 YearsFemaleABHA NO          :DRAWN      :03/03/2025 08:19:29RECEIVED  :03/03/2025 08:22:32REPORTED  :03/03/2025 13:08:25REF. DOCTOR :DR. DR SUNIL SINHACLIENT PATIENT ID:CODE/NAME & ADDRESS  :CR00000037SRL REACH LTD  OPD PATIENT-DHANBADDHANBAD 826001\nFinalResultsBiological Reference IntervalTest Report StatusUnits\nBIOCHEMISTRYCREATININE, SERUMCREATININE1.35  High0.6 - 1.2mg/dLMETHOD : JAFFE KINETIC METHODURIC ACID, SERUMURICACID5.42.5 - 6.8mg/dLMETHOD : URICASE UVGLUCOSE FASTING,FLUORIDE PLASMAFBS(FASTINGBLOODSUGAR)121  High(Normal <100,Impaired fastingglucose:100 to 125,Diabetesmellitus:>=126(on more than1 occasion)(ADA guidelines2024)mg/dLMETHOD : GOD-POD (TRINDER)\nView DetailsView ReportPage 1 Of 3\nDr. Alok KumarConsultant PathologistULR No.775000011409744-0706AgilusDiagnosticsLtdSadarHospitalKasturbaNagar,Dhanbad,826001Jharkhand,IndiaTel:0326-2310050,7260813492Email:customercare.shdhanbad@agilus.inPERFORMED AT :MC-2764DIAGNOSTIC REPORT\nSADARHOSPITAL, PATIENT NAME :  SANDHYA SINHAPATIENT ID       :SANDF260260706ACCESSION NO :0706YC000357AGE/SEX    :66 YearsFemaleABHA NO          :DRAWN      :03/03/2025 08:19:29RECEIVED  :03/03/2025 08:22:32REPORTED  :03/03/2025 13:08:25REF. DOCTOR :DR. DR SUNIL SINHACLIENT PATIENT ID:CODE/NAME & ADDRESS  :CR00000037SRL REACH LTD  OPD PATIENT-DHANBADDHANBAD 826001\nFinalResultsBiological Reference IntervalTest Report StatusUnits\nInterpretation(s)CREATININE,SERUM-Higherthannormallevelmaybedueto:‚Ä¢Blockageintheurinarytract,Kidneyproblems,suchaskidneydamageorfailure,infection,orreducedbloodflow,Lossofbodyfluid(dehydration),Muscleproblems,suchasbreakdownofmusclefibers,Problemsduringpregnancy,suchasseizures(eclampsia)),orhighbloodpressurecausedbypregnancy(preeclampsia)Lowerthannormallevelmaybedueto:‚Ä¢MyastheniaGravis,MuscuophyURICACID,SERUM-CausesofIncreasedlevels:-Dietary(HighProteinIntake,ProlongedFasting,Rapidweightloss),Gout,Leschnyhansyndrome,Type2DM,Metabolicsyndrome Causesofdecreasedlevels-LowZincintake,OCP,MultipleSclerosisGLUCOSEFASTING,FLUORIDEPLASMA-TESTDESCRIPTIONNormally,theglucoseconcentrationinextracellularfluidiscloselyregulatedsothatasourceofenergyisreadilyavailabletotissuesandsothatnoglucoseisexcretedintheurine.Increasedin:Diabetesmellitus,Cushing‚Äôssyndrome(10‚Äì15%),chronicpancreatitis(30%).Drugs:corticosteroids,phenytoin,estrogen,thiazides.Decreasedin:Pancreaticisletcelldiseasewithincreasedinsulin,insulinoma,adrenocorticalinsufficiency,hypopituitarism,diffuseliverdisease,malignancy(adrenocortical,stomach,fibrosarcoma),infantofadiabeticmother,enzymedeficiencydiseases(e.g.galactosemia),Drugs-insulin,ethanol,propranololsulfonylureas,tolbutamide,andotheroralhypoglycemicagents.NOTE:Whilerandomserumglucoselevelscorrelatewithhomeglucosemonitoringresults(weeklymeancapillaryglucosevalues),thereiswidefluctuationwithinindividuals.Thus,glycosylatedhemoglobin(HbA1c)levelsarefavoredtomonitorglycemiccontrol.HighfastingglucoselevelincomparisontopostprandialglucoselevelmaybeseenduetoeffectofOralHypoglycaemics&Insulintreatment,RenalGlyosuria,Glycaemicindex&responsetofoodconsumed,AlimentaryHypoglycemia,Increasedinsulinresponse&sensitivityetc.**End Of Report**Please visit www.agilusdiagnostics.com for related Test Information for this accession\nView DetailsView ReportPage 2 Of 3\nDr. Alok KumarConsultant PathologistULR No.775000011409744-0706AgilusDiagnosticsLtdSadarHospitalKasturbaNagar,Dhanbad,826001Jharkhand,IndiaTel:0326-2310050,7260813492Email:customercare.shdhanbad@agilus.inPERFORMED AT :MC-2764DIAGNOSTIC REPORT\nSADARHOSPITAL, PATIENT NAME :  SANDHYA SINHAPATIENT ID       :SANDF260260706ACCESSION NO :0706YC000357AGE/SEX    :66 YearsFemaleABHA NO          :DRAWN      :03/03/2025 08:19:29RECEIVED  :03/03/2025 08:22:32REPORTED  :03/03/2025 13:08:25REF. DOCTOR :DR. DR SUNIL SINHACLIENT PATIENT ID:CODE/NAME & ADDRESS  :CR00000037SRL REACH LTD  OPD PATIENT-DHANBADDHANBAD 826001\nFinalResultsBiological Reference IntervalTest Report StatusUnits\n5.  AGILUSDiagnosticsconfirmsthatalltestshavebeenperformedorassayedwithhighestqualitystandards,clinicalsafety&technicalintegrity.6.  Laboratoryresultsshouldnotbeinterpretedinisolation;itmustbecorrelatedwithclinicalinformationandbeinterpretedbyregisteredmedicalpractitionersonlytodeterminefinaldiagnosis.7.  Testresultsmayvarybasedontimeofcollection,physiologicalconditionofthepatient,currentmedicationornutritionalanddietarychanges.Pleaseconsultyourdoctororcallusforanyclarification.8.  TestresultscannotbeusedforMedicolegalpurposes.9.  Incaseofqueriespleasecallcustomercare (9111591115)within48hoursofthereport.1. It is presumed that the test sample belongs to the patientnamed or identified in the test requisition form.2. All tests are performed and reported as per theturnaround time stated in the AGILUS Directory of Services.3. Result delays could occur due to unforeseencircumstances such as non-availability of kits / equipmentbreakdown / natural calamities / technical downtime or anyother unforeseen event.4. A requested test might not be performed if:    i. Specimen received is insufficient or inappropriate    ii. Specimen quality is unsatisfactory    iii. Incorrect specimen type    iv. Discrepancy between identification on specimen    container label and test requisition formCONDITIONS OF LABORATORY TESTING & REPORTING\nAgilus Diagnostics LtdFortis Hospital, Sector 62, Phase VIII,Mohali 160062\nView DetailsView ReportPage 3 Of 3\nDr. Alok KumarConsultant PathologistULR No.775000011409744-0706AgilusDiagnosticsLtdSadarHospitalKasturbaNagar,Dhanbad,826001Jharkhand,IndiaTel:0326-2310050,7260813492Email:customercare.shdhanbad@agilus.inPERFORMED AT :','\n',char(10)),'processed',NULL,'6943fda865cf4031806a4e03190d18e4','Agilus Diagnostics Ltd','SANDHYA SINHA','SANDF260260706',66,'Female',NULL,0.966666666666666674);
INSERT INTO pdfs VALUES(5,'575452ab8a9f975275c635beaf27195b35975618e9420a51b758ad3d6019a80e','Aman_full_body_march_2025_1.pdf','uploads/e64c082e-ef69-42c4-82ff-fa60c7dcb360-Aman_full_body_march_2025_1.pdf','2025-04-01 12:41:06.790609','2025-04-01 12:41:36.204844','2025-03-07 00:00:00.000000',replace('CLINICAL PATHOLOGY\n¬†¬†\nUrine Routine Analysis\n¬†¬†\nUrine\nPHYSICAL EXAMINATION\n¬†¬†\nManual\nVolume \n50\nml\nColour \nPale yellow\nPale yellow\nAppearance \nClear\nClear\nCHEMICAL EXAMINATION\n¬†¬†\npH \nDouble indicator method\n6.0\n5.0-8.0\nSpecific gravity \nRefractive Index\n1.030\n1.001-1.035\nUrine Protein \nProtein error of pH indicator \nNil\nNil\nGlucose \nEnzyme method GOD POD\nNil\nNil\nKetone bodies \nDipstick\nNil\nNil\nBilirubin \nAzo coupling method\nNil\nNil\nPage \n1\n / \n2\nTest\nResults\nUnits\nBiological Reference Interval\nOHP46D3D1252442 \nPatient ID\n:\nMr. Mr Aman Ankur\nName\n:\nVisit No.\n:\nBL126133001\nReported On\n07/03/2025 01:47 PM\n:\nCollected On\n07/03/2025 08:07 AM\nReceived On\n:\n07/03/2025 11:17 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n33 Year(s) / Male\nRef. Doctor\n:\nBlood \nPeroxidase activity\nNegative\nNegative\nUrobilinogen \nAzo coupling method\nNormal\nNormal\nLeucocyte Esterase \nGranulocyte esterase method\nNegative\nNegative\nNitrites \nGriess method\nNegative\nNegative\n-- End of Report --\nTests marked with NABL symbol are accredited by NABL vide Certificate no  \nMC-6367\nPage \n2\n / \n2\nDr. Sanchit Singhal\nMD Pathologist\nTest\nResults\nUnits\nBiological Reference Interval\nOHP46D3D1252442 \nPatient ID\n:\nMr. Mr Aman Ankur\nName\n:\nVisit No.\n:\nBL126133001\nReported On\n07/03/2025 01:47 PM\n:\nCollected On\n07/03/2025 08:07 AM\nReceived On\n:\n07/03/2025 11:17 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n33 Year(s) / Male\nRef. Doctor\n:\nBIOCHEMISTRY\n¬†¬†\nFasting Glucose \nF- fluoride plasma\n,\nGOD-POD \n85\nmg/dL\nNormal Fasting Glucose: \n70-99\nImpaired Fasting Glucose: \n100-\n125\nDiabetes : on more than one \noccasion: > \n126\nPage \n1\n / \n12\nTest\nResults\nUnits\nBiological Reference Interval\nOHP46D3D1252442 \nPatient ID\n:\nMr. Mr Aman Ankur\nName\n:\nVisit No.\n:\nBL126133002\nReported On\n07/03/2025 03:55 PM\n:\nCollected On\n07/03/2025 08:07 AM\nReceived On\n:\n07/03/2025 11:18 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n33 Year(s) / Male\nRef. Doctor\n:\nLFT - LIVER FUNCTION TEST\n¬†¬†\nSerum\nTotal Bilirubin \nDSA\n0.65\nmg/dL\nAdult: \n0.2-1.3\nNeonate: \n1.0-10.5\nDirect Bilirubin \nCalculated\n0.33\nmg/dL\nNeonate: \n0.0-0.6\nAdult: \n0.0-0.3\nIndirect Bilirubin \nDual wavelength\n0.32\nmg/dL\nAdult: \n0.1-1.1\nNeonate: \n0.6-10.5\nAspartate Transaminase(AST/ \nSGOT) \nMDH, UV Kinetic\n26\nU/L\n17-49\nAlanine Transaminase(ALT/ \nSGPT) \nLDH, UV kinetic\n30\nU/L\n< 50\nAlkaline Phosphatase \nPNPP, AMP Buffer\n70\nU/L\n38-126\nGamma-Glutamyl Transferase \n(GGT) \nSZAZ Carboxylated Substrate\n17\nU/L\n15-73\nTotal Protein \nBiuret\n7.2\ng/dL\n6.0-8.3\nAlbumin \nBromo-Cresol Green \n4.4\ng/dL\n3.5-5.0\nGlobulin \nCalculated\n2.7\ng/dL\n2.3-3.5\nA/G ratio \nCalculated\n1.6\n0.8-2.0\nPage \n2\n / \n12\nTest\nResults\nUnits\nBiological Reference Interval\nOHP46D3D1252442 \nPatient ID\n:\nMr. Mr Aman Ankur\nName\n:\nVisit No.\n:\nBL126133002\nReported On\n07/03/2025 03:55 PM\n:\nCollected On\n07/03/2025 08:07 AM\nReceived On\n:\n07/03/2025 11:18 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n33 Year(s) / Male\nRef. Doctor\n:\nSGOT/SGPT- RATIO \nCalculated\n0.9\n0.7-1.4\nTotal bilirubin is invariably increased in jaundice. Causes of jaundice are prehepatic, resulting from various hemolytic \ndiseases; hepatic, resulting from hepatocellular injury or obstruction; and posthepatic, resulting from obstruction of the \nhepatic or common bile ducts.\nAspartate aminotransferase is present in high activity in heart, skeletal muscle, and liver. Increased serum AST activity \ncommonly follows myocardial infarction, pulmonary emboli, skeletal muscle trauma, alcoholic cirrhosis, viral hepatitis, \nand drug-induced hepatitis.\nAlanine aminotransferase is present in high activity in liver, skeletal muscle, heart, and kidney. Serum ALT increases \nrapidly in liver cell necrosis, hepatitis, hepatic cirrhosis, liver tumours, obstructive jaundice, Reye\n‚Äô\ns syndrome, \nextensive trauma to skeletal muscle, myositis, myocarditis, and myocardial infarction.\nAlkaline phosphatase is elevated in fever and increased bone metabolism, for example, in adolescents and during the \nhealing of a fracture; primary and secondary hyperparathyroidism; Paget\n‚Äô\ns disease of bone; carcinoma metastatic to \nbone; osteogenic sarcoma; and Hodgkin\n‚Äô\ns disease if bones are invaded. Hepatobiliary diseases involving cholestasis, \ninflammation, or cirrhosis increased ALP activity; also increased in renal infarction and failure and in the complications \nof pregnancy. Low ALP activity may occasionally be seen in hypothyroidism.\nSerum GGT is a sensitive indicator of hepatobiliary disease and is useful in the diagnosis of obstructive jaundice and \nchronic alcoholic liver disease, in the follow-up of chronic alcoholics undergoing treatment, and in the detection of \nhepatotoxicity. GGT is more responsive to biliary obstruction than AST, ALT, or ALP. \nTotal serum protein levels can be used for evaluation of nutritional status. Causes of high total serum protein \nconcentration include dehydration, Waldenstr√∂m\n‚Äô\ns macroglobulinemia, multiple myeloma, hyperglobulinemia, \ngranulomatous diseases, and some tropical diseases. Causes of low total serum protein concentration include \npregnancy, excessive intravenous fluid administration, cirrhosis or other liver diseases, chronic alcoholism, heart \nfailure, nephrotic syndrome, glomerulonephritis, neoplasia, protein-losing enteropathies, malabsorption, and severe \nmalnutrition. \nPage \n3\n / \n12\nTest\nResults\nUnits\nBiological Reference Interval\nOHP46D3D1252442 \nPatient ID\n:\nMr. Mr Aman Ankur\nName\n:\nVisit No.\n:\nBL126133002\nReported On\n07/03/2025 03:55 PM\n:\nCollected On\n07/03/2025 08:07 AM\nReceived On\n:\n07/03/2025 11:18 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n33 Year(s) / Male\nRef. Doctor\n:\n','\n',char(10)),'processed',NULL,'212c0a9391fc4fde9be25eca648133ab',NULL,'Mr Aman Ankur','OHP46D3D1252442',33,'Male',NULL,1.0);
INSERT INTO pdfs VALUES(6,'c550c06eda92952aa3cd1885010575a332b19f0b1d1c1116185c7b83edf9e4e9','Niva_bupa_fullbody.pdf.pdf','uploads/8778e73b-8134-4c97-afe9-363fca835220-Niva_bupa_fullbody.pdf.pdf','2025-04-01 17:27:55.833462','2025-04-01 17:30:01.851053','2024-02-23 00:00:00.000000',replace('BIOCHEMISTRY\n¬†¬†\nFasting Glucose \nF- fluoride plasma\n,\nGOD-POD \n81\nmg/dL\nNormal Fasting Glucose: \n70-99\nImpaired Fasting Glucose: \n100-\n125\nDiabetes : on more than one \noccasion: > \n126\nPage \n1\n / \n15\nTest\nResults\nUnits\nBiological Reference Interval\nOHP2U87Z155060 \nPatient ID\n:\nMr.  Aman Ankur\nName\n:\nVisit No.\n:\nBL74371101\nReported On\n23/02/2024 01:22 PM\n:\nCollected On\n23/02/2024 08:39 AM\nReceived On\n:\n23/02/2024 11:09 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n32 Year(s) / Male\nRef. Doctor\n:\n\n--- Page Break ---\nLFT - LIVER FUNCTION TEST\n¬†¬†\nSerum\nTotal Bilirubin \nDSA\n0.8\nmg/dL\nAdult: \n0.2-1.3\nNeonate: \n1.0-10.5\nDirect Bilirubin \nCalculated\n0.3\nmg/dL\nNeonate: \n0.0-0.6\nAdult: \n0.0-0.3\nIndirect Bilirubin \nDual wavelength\n0.5\nmg/dL\nAdult: \n0.1-1.1\nNeonate: \n0.6-10.5\nAspartate Transaminase(AST/ \nSGOT) \nMDH, UV Kinetic\n25\nU/L\n17-49\nAlanine Transaminase(ALT/ \nSGPT) \nLDH, UV kinetic\n35\nU/L\n< 50\nAlkaline Phosphatase \nPNPP, AMP Buffer\n55\nU/L\n38-126\nGamma-Glutamyl Transferase \n(GGT) \nSZAZ Carboxylated Substrate\n16\nU/L\n15-73\nTotal Protein \nBiuret\n7.0\ng/dL\n6.0-8.3\nAlbumin \nBromo-Cresol Green \n4.1\ng/dL\n3.5-5.0\nGlobulin \nCalculated\n2.9\ng/dL\n2.3-3.5\nA/G ratio \nCalculated\n1.4\n0.8-2.0\nPage \n2\n / \n15\nTest\nResults\nUnits\nBiological Reference Interval\nOHP2U87Z155060 \nPatient ID\n:\nMr.  Aman Ankur\nName\n:\nVisit No.\n:\nBL74371101\nReported On\n23/02/2024 01:22 PM\n:\nCollected On\n23/02/2024 08:39 AM\nReceived On\n:\n23/02/2024 11:09 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n32 Year(s) / Male\nRef. Doctor\n:\n\n--- Page Break ---\nSGOT/SGPT- RATIO \nCalculated\n0.7\n0.7-1.4\nTotal bilirubin is invariably increased in jaundice. Causes of jaundice are prehepatic, resulting from various hemolytic \ndiseases; hepatic, resulting from hepatocellular injury or obstruction; and posthepatic, resulting from obstruction of the \nhepatic or common bile ducts.\nAspartate aminotransferase is present in high activity in heart, skeletal muscle, and liver. Increased serum AST activity \ncommonly follows myocardial infarction, pulmonary emboli, skeletal muscle trauma, alcoholic cirrhosis, viral hepatitis, \nand drug-induced hepatitis.\nAlanine aminotransferase is present in high activity in liver, skeletal muscle, heart, and kidney. Serum ALT increases \nrapidly in liver cell necrosis, hepatitis, hepatic cirrhosis, liver tumours, obstructive jaundice, Reye\n‚Äô\ns syndrome, \nextensive trauma to skeletal muscle, myositis, myocarditis, and myocardial infarction.\nAlkaline phosphatase is elevated in fever and increased bone metabolism, for example, in adolescents and during the \nhealing of a fracture; primary and secondary hyperparathyroidism; Paget\n‚Äô\ns disease of bone; carcinoma metastatic to \nbone; osteogenic sarcoma; and Hodgkin\n‚Äô\ns disease if bones are invaded. Hepatobiliary diseases involving cholestasis, \ninflammation, or cirrhosis increased ALP activity; also increased in renal infarction and failure and in the complications \nof pregnancy. Low ALP activity may occasionally be seen in hypothyroidism.\nSerum GGT is a sensitive indicator of hepatobiliary disease and is useful in the diagnosis of obstructive jaundice and \nchronic alcoholic liver disease, in the follow-up of chronic alcoholics undergoing treatment, and in the detection of \nhepatotoxicity. GGT is more responsive to biliary obstruction than AST, ALT, or ALP. \nTotal serum protein levels can be used for evaluation of nutritional status. Causes of high total serum protein \nconcentration include dehydration, Waldenstr√∂m\n‚Äô\ns macroglobulinemia, multiple myeloma, hyperglobulinemia, \ngranulomatous diseases, and some tropical diseases. Causes of low total serum protein concentration include \npregnancy, excessive intravenous fluid administration, cirrhosis or other liver diseases, chronic alcoholism, heart \nfailure, nephrotic syndrome, glomerulonephritis, neoplasia, protein-losing enteropathies, malabsorption, and severe \nmalnutrition. \nPage \n3\n / \n15\nTest\nResults\nUnits\nBiological Reference Interval\nOHP2U87Z155060 \nPatient ID\n:\nMr.  Aman Ankur\nName\n:\nVisit No.\n:\nBL74371101\nReported On\n23/02/2024 01:22 PM\n:\nCollected On\n23/02/2024 08:39 AM\nReceived On\n:\n23/02/2024 11:09 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n32 Year(s) / Male\nRef. Doctor\n:\n\n--- Page Break ---\nGlycosylated Haemoglobin - (HbA1c)\n¬†¬†\nWhole Blood\nGlycosylated Haemoglobin \n(HbA1c) \nHPLC\n5.5\n%\nNormal: < \n5.7\nPre-Diabetes: \n5.7-6.4\nDiabetes: >= \n6.5\nMean Blood Glucose \nCalculated\n111\nmg/dL\nHbA1C is used to monitor fluctuations in blood glucose concentration in the past 8 to 12 week\n‚Äô\ns period.\nThe reference interval defined as per American Diabetes Association guidelines 2016:\na)     Less than 5.7% : Non Diabetic\nb)    5.7 to 6.4% : at increased risk of developing diabetes in the future\nc)     More than 6.5% : Diabetic\nd)    Therapeutic glycemic target:\ni.      Adults: less than 7%\nii.     Children with Type 1 diabetes : less than 7 %\ne)     Pregnant diabetic patients : less than 6.5%\nNote:\n‚Ä¢  \nTargets may be individualized based on: Age/life expectancy, Comorbid conditions, Diabetes duration , Hypoglycemia status, \nIndividual patient considerations\nReference: American Diabetes Association. Standards of medical care in diabetes\n‚Äî2021.\nMean Blood Glucose is average Blood glucose which directly correlates with A1C, reported in the same units as blood sugar levels \n(mg/dl). Thus it reflects the average glucose concentration in the past 8 to 12 weeks period. This should not be compared with \nFasting or Post prandial or random blood sugar which measures glucose concentration at that point of time of testing.\nPage \n4\n / \n15\nTest\nResults\nUnits\nBiological Reference Interval\nOHP2U87Z155060 \nPatient ID\n:\nMr.  Aman Ankur\nName\n:\nVisit No.\n:\nBL74371101\nReported On\n23/02/2024 01:22 PM\n:\nCollected On\n23/02/2024 08:39 AM\nReceived On\n:\n23/02/2024 11:09 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n32 Year(s) / Male\nRef. Doctor\n:\n\n--- Page Break ---\nKidney Function Test Mini\n¬†¬†\nSerum\nUrea \nUrease \n33\nmg/dL\n19-43\nNewborn: \n6.5-25.5\nBlood Urea Nitrogen (BUN) \nCalculated\n15.4\nmg/dL\n6-20\nCreatinine \nEnzymatic\n1.0\nmg/dL\n0.66-1.25\nBUN Creatinine Ratio \nCalculated\n15.4\nRatio\n10-20\nCalcium \nArsenazo Method \n9.2\nmg/dL\n8.4-10.2\nUric Acid \nUricase\n6.7\nmg/dL\n3.5-8.5\nLipid Profile with calculated LDL\n¬†¬†\nSerum\nTotal Cholesterol \nCHOD-POD\n222\nmg/dl\n< 200\nTriglycerides \nGPO-POD\n206\nmg/dL\n< 150\nHDL Cholesterol \nDirect\n30\nmg/dL\n> 50\nNon-HDL Cholesterol \nCalculated\n192\nmg/dL\n< 130\nLDL Cholesterol \nCalculated\n151\nmg/dL\n< 100\nPage \n5\n / \n15\nTest\nResults\nUnits\nBiological Reference Interval\nOHP2U87Z155060 \nPatient ID\n:\nMr.  Aman Ankur\nName\n:\nVisit No.\n:\nBL74371101\nReported On\n23/02/2024 01:22 PM\n:\nCollected On\n23/02/2024 08:39 AM\nReceived On\n:\n23/02/2024 11:09 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n32 Year(s) / Male\nRef. Doctor\n:\n\n--- Page Break ---\nVLDL Cholesterol \nCalculated\n41\nmg/dL\n< 30\nCholesterol / HDL Ratio \nCalculated\n7.4\n3.30-4.40\nLDL:HDL RATIO \nCalculated\n5\n0.5-3.0\nHDL/LDL RATIO \nCalculated\n0.2\nRatio\n> 0.4\nPage \n6\n / \n15\nTest\nResults\nUnits\nBiological Reference Interval\nOHP2U87Z155060 \nPatient ID\n:\nMr.  Aman Ankur\nName\n:\nVisit No.\n:\nBL74371101\nReported On\n23/02/2024 01:22 PM\n:\nCollected On\n23/02/2024 08:39 AM\nReceived On\n:\n23/02/2024 11:09 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n32 Year(s) / Male\nRef. Doctor\n:\n\n--- Page Break ---\nLipid profile is a group test consisting of various lipids. Lipid profiles are generally collected with overnight fasting. \nHowever, \nRecent guidelines have \nrecommended non fasting samples for lipid profile for assessment of cardiovascular risk.\n The details for the study can be checked at\n \nhttps://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2733560\nIn certain instances measurements in the same patient can show physiological and analytical variations. In such cases three serial samples at an interval of 1 \nweek each are recommended for Total cholesterol, TG, HDL and LDL.\nCholesterol levels\n are increased in primary hypercholesterolemia; secondary hyperlipoproteinemia, including nephrotic syndrome; primary biliary cirrhosis; \nhypothyroidism; and in some cases, diabetes mellitus. Low cholesterol levels may be found in malnutrition, malabsorption, advanced malignancy, and \nhyperthyroidism. \nTriglyceride levels\n are used in the diagnosis and treatment of patients with diabetes mellitus, nephrosis, liver obstruction, other diseases involving lipid \nmetabolism, or various endocrine disorders.\nHigh Density Lipoprotein (HDL) cholesterol levels\n is used to evaluate the risk of developing coronary heart disease (CHD). The risk of CHD increases with \nlower HDL cholesterol concentrations.\n \nLDL (low-density lipoprotein) cholesterol level\n, sometimes called \n‚Äú\nbad\n‚Äù \ncholesterol, makes up most of our body\n‚Äô\ns cholesterol. High levels of LDL cholesterol \nraise your risk for heart disease and stroke.\n \nVery-low-density lipoprotein (VLDL)\n cholesterol is produced in the liver and released into the bloodstream to supply body tissues with triglycerides. High \nlevels of VLDL cholesterol have\nbeen associated with the development of plaque deposits on artery walls, which narrow the passage and restrict blood flow.\nREMARKS\nTOTAL CHOLESTEROL(mg/dL)\nTRIGLYCERIDE(mg/dL)\nLDL CHOLESTEROL(mg/dL)\nOptimal\n<200\n<150\n<100\nAbove Optimal\n-\n-\n100-129\nBorderline\n200-239\n150-199\n130-159\nHigh\n>=240\n200-499\n160-189\nVery High\n-\n>=500\n>=190\nPage \n7\n / \n15\nDr. Sanchit Singhal\nMD Pathologist\nTest\nResults\nUnits\nBiological Reference Interval\nOHP2U87Z155060 \nPatient ID\n:\nMr.  Aman Ankur\nName\n:\nVisit No.\n:\nBL74371101\nReported On\n23/02/2024 01:22 PM\n:\nCollected On\n23/02/2024 08:39 AM\nReceived On\n:\n23/02/2024 11:09 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n32 Year(s) / Male\nRef. Doctor\n:\n\n--- Page Break ---\nIMMUNOLOGY\n¬†¬†\nThyroid Stimulating Hormone \n(TSH) \nSerum\n,\nCLIA\n2.570\n¬µIU/mL\n0.400-4.049\nThyroid Stimulating Hormone (TSH), also called Thyrotropin is a hormone secreted into the blood by the Pituitary gland (a gland present in the \nbrain)). It signals the thyroid gland to make and release the thyroid hormones (T3 & T4) into the blood.\nHigh TSH level\n indicates that the thyroid gland is not making enough thyroid hormone (primary hypothyroidism).\nLow TSH level usually\n indicates that the thyroid is producing too much thyroid hormone (hyperthyroidism).\nFactors influencing TSH levels\nFasting\n: TSH level shows a significant decline after meal intake in comparison to fasting values. This may have clinical implications in the \ndiagnosis and management of hypothyroidism, especially Subclinical hypothyroidism.\n1\nCircadian Rhythm:\n TSH levels follow a circadian variation, reaching peak levels between Morning 2 \n‚Äì 4 \nam and at a minimum between Evening 6-\n10 pm. The variation is of the order of 50%. hence time of sample collection during a day can significantly influence on the measured serum TSH \nconcentrations.\n2\nOther Factors\n: Genetics, Poisonous substances and radiation exposure, Inflammation of the thyroid gland, Deficiency or excess of iodine in the \ndiet, Pregnancy, Certain medications \n‚Äì \nantidepressants, cholesterol lowering drugs, chemotherapy drugs, steroids, Thyroid cancer.\nReferences:\n1.\n \nIndian Journal of Endocrinology and Metabolism \n18(5):p 705-707, Sep\n‚Äì\nOct 2014.)\n2.\n \nefaidnbmnnnibpcajpcglclefindmkaj/http://www.pnei-it.com/1/upload/thyrotropin_secretion_patterns_i\n n_health_and_disease.pdf\nIn pregnant females the reference range of TSH differs. Please refer the table below for the same:-\nPregnancy\nTSH Reference Range (uIU/mL)\n1st Trimester\n0.129-3.120\n2nd Trimester\n0.274-2.652\n3rd Trimester\n0.312-2.947\nPage \n8\n / \n15\nTest\nResults\nUnits\nBiological Reference Interval\nOHP2U87Z155060 \nPatient ID\n:\nMr.  Aman Ankur\nName\n:\nVisit No.\n:\nBL74371101\nReported On\n23/02/2024 01:22 PM\n:\nCollected On\n23/02/2024 08:39 AM\nReceived On\n:\n23/02/2024 11:09 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n32 Year(s) / Male\nRef. Doctor\n:\n\n--- Page Break ---\nVitamin D (25 OH \nCholecalciferol) \nSerum\n,\nCLIA\n64.1\nng/mL\nDeficient: < \n20\nInsufficient: \n20-30\nSufficient: \n30-100\nToxicity: > \n100\nFor the diagnosis of vitamin D deficiency it is recommended to have clinical correlation with serum 25\n(OH)vitamin D, serum calcium, serum PTH & serum alkaline phosphatase.\nDuring the monitoring of oral vitamin D therapy - suggested testing of serum 25(OH)vitamin D is after 12 \nweeks or 3 months of treatment. However, the required dosage of vitamin D supplements & time to achieve \nsufficient vitamin D levels show significant seasonal (especially winter) & individual variability depending on \nage, body fat, sun exposure, physical activity, genetic factors (especially variable vitamin D receptor \nresponses), associated liver or renal disease, malabsorption syndromes and calcium or magnesium \ndeficiency influencing the vitamin D metabolism.\nPage \n9\n / \n15\nDr. Sanchit Singhal\nMD Pathologist\nTest\nResults\nUnits\nBiological Reference Interval\nOHP2U87Z155060 \nPatient ID\n:\nMr.  Aman Ankur\nName\n:\nVisit No.\n:\nBL74371101\nReported On\n23/02/2024 01:22 PM\n:\nCollected On\n23/02/2024 08:39 AM\nReceived On\n:\n23/02/2024 11:09 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n32 Year(s) / Male\nRef. Doctor\n:\n\n--- Page Break ---\nHEMATOLOGY\n¬†¬†\nComplete Blood Count with ESR\n¬†¬†\nWhole Blood\nRBC count \nDC Impedance method\n4.89\nmill/cu.mm\n4.5-5.5\nHaemoglobin (Hb) \nCyanide-free SLS method\n14.6\ngm/dL\n13.0-17.0\nHaematocrit(PCV) \nCalculated\n43.5\n%\n40-50\nMean Corpuscular Volume\n(MCV) \nBased on RBC Histogram\n88.9\nfL\n83-101\nMean Corpuscular \nHaemoglobin(MCH) \nCalculated\n29.8\npg\n27-32\nMean Corpuscular \nHaemoglobin Concentration\n(MCHC) \nCalculated\n33.6\ng/dL\n31.5-34.5\nRed cell distribution width \n(RDW) \nCalculated\n13.2\n%\n11.6-14.0\nMentzer Index \nCalculated\n18.2\nIndex\nBeta Thalassemia trait: < \n14\nIron deficiency anaemia: >= \n14\nSehgal index \nCalculated\n1616.2\nIndex\nBeta Thalassemia trait: < \n972\nIron deficiency anaemia: >= \n972\nPage \n10\n / \n15\nTest\nResults\nUnits\nBiological Reference Interval\nOHP2U87Z155060 \nPatient ID\n:\nMr.  Aman Ankur\nName\n:\nVisit No.\n:\nBL74371101\nReported On\n23/02/2024 01:22 PM\n:\nCollected On\n23/02/2024 08:39 AM\nReceived On\n:\n23/02/2024 11:09 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n32 Year(s) / Male\nRef. Doctor\n:\n\n--- Page Break ---\nTotal WBC count - TC \nDC Impedance method\n7540\ncells/cu.mm\n4000-10000\nDifferential Leucocyte Count - DC\n¬†¬†\nFlow Cytometry\nNeutrophils \n57.4\n%\n40-80\nLymphocytes \n28.1\n%\n20-40\nMonocytes \n7.8\n%\n2-10\nEosinophils \n6.3\n%\n1-6\nBasophils \n0.4\n%\n0-2\nAbsolute Neutrophil Count \nCalculated\n4328\n/ cu.mm\n2000-7000\nAbsolute Lymphocyte Count \nCalculated\n2119\n/ cu.mm\n1000-3000\nAbsolute Monocyte Count \nCalculated\n588\n/ cu.mm\n200-1000\nAbsolute Eosinophil Count \nCalculated\n475\n/ cu.mm\n20-500\nAbsolute Basophil Count \nCalculated\n30\n/ cu.mm\n0-100\nNeutrophil Lymphocyte Ratio \n(NLR) \nCalculated\n2.0\nRatio\n1.0-3.0\nPage \n11\n / \n15\nTest\nResults\nUnits\nBiological Reference Interval\nOHP2U87Z155060 \nPatient ID\n:\nMr.  Aman Ankur\nName\n:\nVisit No.\n:\nBL74371101\nReported On\n23/02/2024 01:22 PM\n:\nCollected On\n23/02/2024 08:39 AM\nReceived On\n:\n23/02/2024 11:09 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n32 Year(s) / Male\nRef. Doctor\n:\n\n--- Page Break ---\nPlatelet count \nDC Impedance method\n271\n10^3/ul\n150-450\nPlatelet hematocrit \nCalculated\n0.288\n%\n0.20-0.50\nMean Platelet Volume (MPV) \nCalculated\n10.6\nfL\n7-13\nErythrocyte Sedimentation \nRate \nQuantitative Capillary Photometry\n5\nmm/hr\n0-10\n1. Reference Ranges are in accordance with Dacie & Lewis Practical Hematology International Edition (12th).\n2. As per International Council for Standardization in Hematology''s recommendations Differential Leucocyte counts are additionally reported in \nAbsolute numbers in each cell per unit volume of blood.\nDr. Sanchit Singhal\nMD Pathologist\nPage \n12\n / \n15\nDr. Madhutej TH\nMD Pathologist\nTest\nResults\nUnits\nBiological Reference Interval\nOHP2U87Z155060 \nPatient ID\n:\nMr.  Aman Ankur\nName\n:\nVisit No.\n:\nBL74371101\nReported On\n23/02/2024 01:22 PM\n:\nCollected On\n23/02/2024 08:39 AM\nReceived On\n:\n23/02/2024 11:09 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n32 Year(s) / Male\nRef. Doctor\n:\n\n--- Page Break ---\nCLINICAL PATHOLOGY\n¬†¬†\nUrine Complete Analysis\n¬†¬†\nUrine\nPHYSICAL EXAMINATION\n¬†¬†\nManual\nVolume \n20\nml\nColour \nPale yellow\nPale yellow\nAppearance \nClear\nClear\nCHEMICAL EXAMINATION\n¬†¬†\npH \nDouble indicator method\n6.0\n5.0-8.0\nSpecific gravity \nRefractive Index\n1.015\n1.001-1.035\nUrine Protein \nProtein error of pH indicator \nNil\nNil\nGlucose \nEnzyme method GOD POD\nNil\nNil\nKetone bodies \nDipstick\nNil\nNil\nBilirubin \nAzo coupling method\nNil\nNil\nPage \n13\n / \n15\nTest\nResults\nUnits\nBiological Reference Interval\nOHP2U87Z155060 \nPatient ID\n:\nMr.  Aman Ankur\nName\n:\nVisit No.\n:\nBL74371101\nReported On\n23/02/2024 01:22 PM\n:\nCollected On\n23/02/2024 08:39 AM\nReceived On\n:\n23/02/2024 11:09 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n32 Year(s) / Male\nRef. Doctor\n:\n\n--- Page Break ---\nBlood \nPeroxidase activity\nNegative\nNegative\nUrobilinogen \nAzo coupling method\nNormal\nNormal\nLeucocyte Esterase \nGranulocyte esterase method\nNegative\nNegative\nNitrites \nGriess method\nNegative\nNegative\nMICROSCOPY EXAMINATION\n¬†¬†\nFlow digital Imaging\nPus cells \n2-3\n/hpf\n0-5\nEpithelial cells \n0-1\n/hpf\n0-2\nRBCs \nNil\n/hpf\n0-2\nGranular Casts \nNil\n/hpf\nNil\nHyaline Casts \nNil\n/hpf\nOccasional\nUric acid Crystals \nNil\n/hpf\nNil\nPhosphate Crystals \nNil\n/hpf\nNil\nCalcium Oxalate Crystals \nNil\n/hpf\nNil\nPage \n14\n / \n15\nTest\nResults\nUnits\nBiological Reference Interval\nOHP2U87Z155060 \nPatient ID\n:\nMr.  Aman Ankur\nName\n:\nVisit No.\n:\nBL74371101\nReported On\n23/02/2024 01:22 PM\n:\nCollected On\n23/02/2024 08:39 AM\nReceived On\n:\n23/02/2024 11:09 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n32 Year(s) / Male\nRef. Doctor\n:\n\n--- Page Break ---\nAmorphous urates \nNil\n/hpf\nNil\nAmorphous phosphates \nNil\n/hpf\nNil\nYeast \nNil\n/hpf\nNil\nBacteria \nNil\n/hpf\nNil\nParasites \nNil\n/hpf\nNil\nMucus \nNil\nNil\nIncreased \nprotein\n in urine is seen in dehydration, kidney disorders, heart failure and transplant rejection. 24 hour urine protein and \nProtein/creatinine ratio in a random urine sample recommended if increased.\nGlucosuria\n can be seen in kidney disorders, uncontrolled diabetes mellitus, hormonal disorders, and pregnancy. To be correlated \nwith plasma glucose levels.\nKetonuria\n is seen in physical exercise, starvation, severe vomiting, exposure to cold, uncontrolled diabetes (diabetic ketoacidosis)\nIncreased \nbilirubin\n levels should be followed up with Liver function tests and indicates conjugated hyperbilirubinemia. \nIncreased \nurobilinogen\n can be seen due to haemolysis, megaloblastic anaemia and haemorrhage in tissues. Urobilinogen is \nabsent or reduced in obstructive liver disease and antibiotic therapy.\nRBCs\n in urine (Haematuria) can be seen in anticoagulant therapy, bleeding diathesis and traumatic catheterization history to be \nlooked into. Dysmorphic RBCs suggestive of glomerular pathology. Non glomerular diseases line calculus, infections, tumours, \nafter strenuous exercise and diseases of the prostate.\nIncrease in \npus cells\n are elevated in cases of UTI, to be correlated with urine culture, if clinically indicated. \nInfection can be in \neither the upper or lower urinary tract or with acute glomerulonephritis, tubule interstitial nephritis. Leucocyte esterase detects \nesterase enzyme released from the granules of leucocytes.\nInfected urine may contain considerable amounts of \nnitrite\n as a result of bacterial nitrate reductase activity, and detection of nitrite \nin urine is routinely used in the diagnosis of bacterial cystitis.\n It is indicative of the requirement of Urine culture and sensitivity \ntesting for identification and treatment of UTI.\nHyaline casts\n are \nseen normally (not associated with disease states); seen after strenuous exercise and with non renal diseases, \nsuch as dehydration.\nGranular casts\n can be seen in acute glomerulonephritis and pyelonephritis.\n-- End of Report --\nDr. Sanchit Singhal\nMD Pathologist\nPage \n15\n / \n15\nDr. Madhutej TH\nMD Pathologist\nTest\nResults\nUnits\nBiological Reference Interval\nOHP2U87Z155060 \nPatient ID\n:\nMr.  Aman Ankur\nName\n:\nVisit No.\n:\nBL74371101\nReported On\n23/02/2024 01:22 PM\n:\nCollected On\n23/02/2024 08:39 AM\nReceived On\n:\n23/02/2024 11:09 AM\n:\n:\nAge / Sex\nClient\n:\nGetvisit TPA \n32 Year(s) / Male\nRef. Doctor\n:\n','\n',char(10)),'processed',NULL,'212c0a9391fc4fde9be25eca648133ab',NULL,'Mr. Aman Ankur','OHP2U87Z155060',32,'Male',NULL,0.995090909090908803);
INSERT INTO pdfs VALUES(7,'c23d265237a7e3a5330be113d5ac371a9a0b0f391ccecb18b37e68946647c6d6','PDF document-F6291DA9DCCF-1.pdf','uploads/d2194bc2-f5e6-45d3-9cb8-61c1cdf0ef37-PDF document-F6291DA9DCCF-1.pdf','2025-04-02 14:24:08.380834',NULL,NULL,replace('Ekacare - Bangalore office Onsite\nHemoglobin (HB)\nHemoglobin\nSpectrophotometry14.9 g/dL 13.0 - 17.0\nInterpretation:\n1.Hemoglobin is a protein contained in red blood cells which is responsible for oxygen delivery to tissues.\n2.To achieve adequate tissue oxygenation , a sufficient level is required.\n3.Low levels indicate anemia and further testing may be required to evaluate the cause.\n4.High levels may be seen in persons living at high altitude , dehydration, smoking and some blood disorders.\n....\nPatient NAME : Mr aman ankur\nDOB/Age/Gender : 32 Y/Male\nPatient ID / UHID : 9243232/RCL8592877\nReferred BY : Self\nSample Collected : Aug 07, 2024, 03:00 AM \nReport STATUS : Final Report\nBarcode NO : HQ128533\nSample Type : Whole blood EDTA\nReport Date : Aug 07, 2024, 08:10 PM.\nTest Description Value(s) Unit(s) Reference Range\n¬†\n¬†¬†¬†¬†\nBooking¬†Centre¬†:-¬†EkaCare¬†Camps,¬†Villa¬†No¬†28,.¬†Windmills¬†of¬†your¬†mind,Opp.¬†L&T¬†Infotech,.¬†Plot¬†No-331/A,.¬†Road¬†No\n5,¬†EPIP.¬†Bangalore,.¬†Karnataka¬†560066\nProcessing¬†Lab¬†:-¬† Redcliffe¬†Lifetech¬†Pvt.¬†Ltd.,¬†Building¬†No.168,First¬†Floor¬†Sarathy,9¬†Main¬†Sector¬†6¬†HRS¬†Layout,\nBangalore¬†560102Page 1 of 4\n\n--- Page Break ---\nHbA1C (Glycosylated Haemoglobin)\nGlycosylated Hemoglobin (HbA1c)\nHPLC5.5 % <5.7\nEstimated Average Glucose\ncalculated.111.15 mg/dL -\nInterpretation:\nInterpretation For HbA1c% As per American Diabetes Association (ADA)\nReference Group HbA1c in %\nNon diabetic adults >=18 years <5.7\nAt risk (Prediabetes) 5.7 - 6.4\nDiagnosing Diabetes >= 6.5\nTherapeutic goals for glycemic controlAge > 19 years\nGoal of therapy: < 7.0\nAge < 19 years\nGoal of therapy: <7.5\nNote:\n1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still\nhave a high concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled.\n2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular\ndisease. In patients with significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0 %\nmay not be appropriate.\nComments :\nHbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term glycemic control as\ncompared to blood and urinary glucose determinations ADA criteria for correlation between HbA1c & Mean plasma glucose levels.\nHbA1c(%) Mean Plasma Glucose (mg/dL) HbA1c(%) Mean Plasma Glucose (mg/dL)\n6 126 12 298\n8 183 14 355\n10 240 16 413\n    \n \n....\nPatient NAME : Mr aman ankur\nDOB/Age/Gender : 32 Y/Male\nPatient ID / UHID : 9243232/RCL8592877\nReferred BY : Self\nSample Collected : Aug 07, 2024, 03:00 AM \nReport STATUS : Final Report\nBarcode NO : HQ128533\nSample Type : Whole blood EDTA\nReport Date : Aug 07, 2024, 08:36 PM.\nTest Description Value(s) Unit(s) Reference Range\n¬†\n¬†¬†¬†¬†\nBooking¬†Centre¬†:-¬†EkaCare¬†Camps,¬†Villa¬†No¬†28,.¬†Windmills¬†of¬†your¬†mind,Opp.¬†L&T¬†Infotech,.¬†Plot¬†No-331/A,.¬†Road¬†No\n5,¬†EPIP.¬†Bangalore,.¬†Karnataka¬†560066\nProcessing¬†Lab¬†:-¬† Redcliffe¬†Lifetech¬†Pvt.¬†Ltd.,¬†Building¬†No.168,First¬†Floor¬†Sarathy,9¬†Main¬†Sector¬†6¬†HRS¬†Layout,\nBangalore¬†560102Page 2 of 4\n\n--- Page Break ---\nLipid Profile\nTotal Cholesterol\nenzymatic CHOD-PAP256 mg/dL <200\nTriglycerides\nGlycerol phosphate oxidase391 mg/dL <150\nHDL Cholesterol\ncholesterol oxidase and peroxidase31 mg/dL >40\nNon HDL Cholesterol\nCalculated225 mg/dL <130\nLDL Cholesterol\nCalculated146.8 mg/dL <100\nV.L.D.L Cholesterol\nCalculated78.2 mg/dL < 30\nChol/HDL Ratio\nCalculated8.26 Ratio 3.5 - 5.0\nHDL/ LDL Ratio\nCalculated0.21 Ratio 0.5 - 3.0\nLDL/HDL Ratio\nCalculated4.74 Ratio -\nInterpretation:\nLipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous interpretation. NCEP recommends of 3\ndifferent samples to be drawn at intervals of 1 week for harmonizing biological variables that might be encountered in single assays.\n \nNational Lipid Association Recommendations\n(NLA-2014)Total Cholesterol\n(mg/dL)Triglyceride\n(mg/dL)LDL Cholesterol\n(mg/dL)Non HDL Cholesterol\n(mg/dL)\nOptimal <200 <150 <100 <130\nAbove Optimal   100-129 130 - 159\nBorderline High 200-239 150-199 130-159 160 - 189\nHigh >=240 200-499 160-189 190 - 219\nVery High - >=500 >=190 >=220\nHDL Cholesterol\nLow High\n<40 >=60\n \n Risk Stratification for ASCVD (Atherosclerotic Cardiovascular Disease) by Lipid Association of India.\n \nRisk Category A. CAD with > 1 feature of high risk group\nExtreme risk groupB. CAD with >1 feature of very high risk group of recurrent ACS (within 1 year) despite LDL-C <or = 50 mg/dl\nor poly vascular disease\nVery High Risk1.Established ASCVD 2.Diabetes with 2 major risk factors of evidence of end organ\ndamage 3. Familial Homozygous Hypercholesterolemia\n1. Three major ASCVD risk factors 2. Diabetes with 1 major risk factor or no evidence\n....\nPatient NAME : Mr aman ankur\nDOB/Age/Gender : 32 Y/Male\nPatient ID / UHID : 9243232/RCL8592877\nReferred BY : Self\nSample Collected : Aug 07, 2024, 03:00 AM \nReport STATUS : Final Report\nBarcode NO : ZD930066\nSample Type : Serum\nReport Date : Aug 07, 2024, 08:12 PM.\nTest Description Value(s) Unit(s) Reference Range\n¬†\n¬†¬†¬†¬†\nBooking¬†Centre¬†:-¬†EkaCare¬†Camps,¬†Villa¬†No¬†28,.¬†Windmills¬†of¬†your¬†mind,Opp.¬†L&T¬†Infotech,.¬†Plot¬†No-331/A,.¬†Road¬†No\n5,¬†EPIP.¬†Bangalore,.¬†Karnataka¬†560066\nProcessing¬†Lab¬†:-¬† Redcliffe¬†Lifetech¬†Pvt.¬†Ltd.,¬†Building¬†No.168,First¬†Floor¬†Sarathy,9¬†Main¬†Sector¬†6¬†HRS¬†Layout,\nBangalore¬†560102Page 3 of 4\n\n--- Page Break ---\nHigh Riskof end organ damage 3. CHD  stage 3B or 4.  4 LDL >190 mg/dl 5. Extreme of a single\nrisk factor 6. Coronary Artery Calcium - CAC > 300 AU  7. Lipoprotein a >/= 50 mg/dl\n8. Non stenotic carotid  plaque\nModerate Risk 2 major ASCVD risk factors\nLow Risk 0-1 major ASCVD risk factors\nMajor ASCVD (Atherosclerotic cardiovascular disease) Risk Factors\n1. Age >/=45 years in Males &\n    >/= 55 years    in   Females3. Current Cigarette smoking or  tobacco use\n2. Family history of premature\nASCVD4. High blood pressure\n5. Low HDL  \nNewer treatment goals and statin initiation thresholds based on the risk categories proposed by Lipid Association of India\nin 2020.\n \nRisk Group Treatment Goals Consider Drug Therapy\n  LDL-C (mg/dl)  Non-HDL (mg/dl) LDL-C (mg/dl) Non-HDL (mg/dl)\nExtreme Risk Group  Category A  <50 (Optional goal <OR = 30)  <80 (Optional goal <OR = 60) >OR = 50 >OR = 80\nExtreme Risk Group  Category B  >OR = 30  >OR =  60 > 30 > 60\nVery High Risk <50 <80 >OR =  50 >OR =  80\nHigh Risk <70 <100 >OR =  70 >OR =  100\nModerate Risk <100 <130 >OR =  100 >OR =  130\nLow Risk <100 <130 >OR =  130* >OR =  160\n* After an adequate non-pharmacological intervention for at least 3 months.\nReferences : Management of Dyslipidaemia for the Prevention of Stroke : Clinical practice Recommendations from the Lipid Association of\nIndia. Current Vascular Pharmacology,2022,20,134-155.\n*** End Of Report ***\nPatient NAME : Mr aman ankur\nDOB/Age/Gender : 32 Y/Male\nPatient ID / UHID : 9243232/RCL8592877\nReferred BY : Self\nSample Collected : Aug 07, 2024, 03:00 AM \nReport STATUS : Final Report\nBarcode NO : ZD930066\nSample Type : Serum\nReport Date : Aug 07, 2024, 08:12 PM.\nTest Description Value(s) Unit(s) Reference Range\n¬†\n¬†¬†¬†¬†\nBooking¬†Centre¬†:-¬†EkaCare¬†Camps,¬†Villa¬†No¬†28,.¬†Windmills¬†of¬†your¬†mind,Opp.¬†L&T¬†Infotech,.¬†Plot¬†No-331/A,.¬†Road¬†No\n5,¬†EPIP.¬†Bangalore,.¬†Karnataka¬†560066\nProcessing¬†Lab¬†:-¬† Redcliffe¬†Lifetech¬†Pvt.¬†Ltd.,¬†Building¬†No.168,First¬†Floor¬†Sarathy,9¬†Main¬†Sector¬†6¬†HRS¬†Layout,\nBangalore¬†560102Page 4 of 4\n','\n',char(10)),'processing',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL);
INSERT INTO pdfs VALUES(8,'44119fff0285da91772393b102b565c600d984980e16febcdd24f46b58cedb3b','Pharmeasy Order D3508939 Report.pdf','uploads/5a4e9946-f0a9-4bc8-a449-224b122419fc-Pharmeasy Order D3508939 Report.pdf','2025-04-02 14:32:23.661351','2025-04-02 14:35:10.389693','2023-08-05 00:00:00.000000',replace('Aman Ankur(31Y/M)\nAarogyam Full Body Checkup With Vitamins - New , Ftes\n05 Aug 2023 Partal ReportReport for\nTests asked\nTest date Report status\n--- Page Break ---\nK 1902 BRIGADE METROPOLIS \nGARUDACHARYAPALYA MAHADEVPURA \nMAHDEVPURA WHITEFIELD RD BENGALURUName\nSELFAMAN ANKUR(31Y/M)\nRef. By:\n:\nNote :  This is only a partial report. Please refer to the table below for the detailsReport Availability Summary\n19 Reports Available 1 Reports In-Process\nADDRESS :\nTest Report Status\nAvailable ‚óè AAROGYAM FULL BODY CHECKUP WITH VITAMINS - NEW\nAvailable ‚ÄÉ‚ÄÉ25-OH VITAMIN D (TOTAL)\nAvailable ‚ÄÉ‚ÄÉCARDIAC RISK MARKERS\nAvailable ‚ÄÉ‚ÄÉCHLORIDE\nAvailable ‚ÄÉ‚ÄÉCOMPLETE URINE ANALYSIS\nAvailable ‚ÄÉ‚ÄÉFASTING BLOOD SUGAR(GLUCOSE)\nAvailable ‚ÄÉ‚ÄÉHbA1c\nAvailable ‚ÄÉ‚ÄÉHEMOGRAM - 6 PART (DIFF)\nAvailable ‚ÄÉ‚ÄÉIRON\nAvailable ‚ÄÉ‚ÄÉKIDPRO\nAvailable ‚ÄÉ‚ÄÉLIPID PROFILE\nAvailable ‚ÄÉ‚ÄÉLIVER FUNCTION TESTS\nAvailable ‚ÄÉ‚ÄÉSODIUM\nAvailable ‚ÄÉ‚ÄÉTOTAL IRON BINDING CAPACITY (TIBC)\nAvailable ‚ÄÉ‚ÄÉTOTAL THYROXINE (T4)\nAvailable ‚ÄÉ‚ÄÉTOTAL TRIIODOTHYRONINE (T3)\nAvailable ‚ÄÉ‚ÄÉTSH - ULTRASENSITIVE\nAvailable ‚ÄÉ‚ÄÉUNSAT.IRON-BINDING CAPACITY(UIBC)\nAvailable ‚ÄÉ‚ÄÉVITAMIN B-12\nClinically Tested by :  Thyrocare Technologies Ltd. Note :  Underlined values are Critical Values, Clinician''s attention required.\n\n--- Page Break ---\nK 1902 BRIGADE METROPOLIS \nGARUDACHARYAPALYA MAHADEVPURA \nMAHDEVPURA WHITEFIELD RD BENGALURUName\nSELFAMAN ANKUR(31Y/M)\nRef. By:\n:\nNote :  This is only a partial report. Please refer to the table below for the detailsReport Availability Summary\n19 Reports Available 1 Reports In-Process\nADDRESS :\nTest Report Status\nIn Processing ‚óè FREE TESTOSTERONE\nClinically Tested by :  Thyrocare Technologies Ltd. Note :  Underlined values are Critical Values, Clinician''s attention required.\n\n--- Page Break ---\nNAME  \nSELFAMAN ANKUR(31Y/M)\nREF. BY\nTEST ASKED AAROGYAM FULL BODY CHECKUP WITH VITAMINS - \nNEW, FREE TESTOSTERONE:\n:\n:K 1902 BRIGADE METROPOLIS \nGARUDACHARYAPALYA MAHADEVPURA \nMAHDEVPURA WHITEFIELD RD BENGALURUHOME COLLECTION :\nTEST NAME TECHNOLOGY VALUE UNITS\n40.45 C.L.I.A ng/mL 25-OH VITAMIN D (TOTAL)\nDEFICIENCY : <20 ng/ml || INSUFFICIENCY : 20-<30 ng/ml \nSUFFICIENCY : 30-100 ng/ml || TOXICITY : >100 ng/ml\nClinical Significance:\nVitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; \nboth are critical for building bone health. Decrease in vitamin D total levels indicate inadequate exposure of sunlight , \ndietary deficiency, nephrotic syndrome. Increase in vitamin D total levels indicate Vitamin  D intoxication .\nSpecifications: Precision: Intra assay (%CV):5.3%, Inter assay (%CV):11.9% ; Sensitivity :3.2 ng/ml.\nKit Validation Reference : Holick MF. Vitamin D Deficiency. N Engl J Med. 2007;357:266‚Äì81.Reference Range :\nMethod : FULLY AUTOMATED  CHEMI LUMINESCENT IMMUNO ASSAY\n434 C.L.I.A pg/mL VITAMIN B-12\nNormal :  211 - 911 pg/ml\nClinical significance :\nVitamin B12 or cyanocobalamin , is a complex corrinoid compound found exclusively from animal dietary sources , such as \nmeat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the \nformation of myelin sheath .  Vitamin-B12 is used to find out neurological abnormalities and impaired DNA synthesis \nassociated with macrocytic anemias. For diagnostic purpose , results should always be assessed in conjunction with the \npatients medical history, clinical examination and other findings.\nSpecifications: Intra assay (%CV):5.0%, Inter assay (%CV):9.2 %; Sensitivity :45 pg/ml\nKit Validation reference :\nChen IW, Sperling MI, Heminger LA. Vitamin B12. In: Pesce AJ , Kaplan LA , eds. Methods in Clinical Chemistry. St. Louis: CV \nMosby; 1987:569‚Äì73.Reference Range :\nMethod : COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\nPlease correlate with clinical conditions. \nSERUM05 Aug 2023 15:1505 Aug 2023 12:3005 Aug 2023 08:13 :\n:\n:\n: Sample TypeReport  Released on (RRT)Sample Received on (SRT)\nBE329513: Barcode:0508040464/DG007 Labcode\nPage : 1 of 14Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD (Path)\nSample Collected on (SCT)\nNote:- Underlined values are Critical Values , Clinician''s attention required. Clinically Tested by :Thyrocare Technologies Ltd\n\n--- Page Break ---\nNAME  \nSELFAMAN ANKUR(31Y/M)\nREF. BY\nTEST ASKED AAROGYAM FULL BODY CHECKUP WITH VITAMINS - \nNEW, FREE TESTOSTERONE:\n:\n:K 1902 BRIGADE METROPOLIS \nGARUDACHARYAPALYA MAHADEVPURA \nMAHDEVPURA WHITEFIELD RD BENGALURUHOME COLLECTION :\nTEST NAME TECHNOLOGY VALUE UNITS\n110 IMMUNOTURBIDIMETRY mg/dL APOLIPOPROTEIN - A1 (APO-A1)\nMale :   86 - 152\nFemale :   94 - 162Reference Range :\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY ‚Äì BECKMAN COULTER\n134 IMMUNOTURBIDIMETRY mg/dL APOLIPOPROTEIN - B (APO-B)\nMale :   56 - 145\nFemale :   53 - 138Reference Range :\nMethod : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY ‚Äì BECKMAN COULTER\n1.2 CALCULATED Ratio APO B / APO A1 RATIO (APO B/A1)\n Male :  0.40  -  1.26\n Female :  0.38  -  1.14Reference Range :\nMethod : DERIVED FROM SERUM APO A1 AND APO B  VALUES\nPlease correlate with clinical conditions. \nSERUM05 Aug 2023 15:1505 Aug 2023 12:3005 Aug 2023 08:13 :\n:\n:\n: Sample TypeReport  Released on (RRT)Sample Received on (SRT)\nBE329513: Barcode:0508040464/DG007 Labcode\nPage : 2 of 14Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD (Path)\nSample Collected on (SCT)\nNote:- Underlined values are Critical Values , Clinician''s attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)\n\n--- Page Break ---\nNAME  \nSELFAMAN ANKUR(31Y/M)\nREF. BY\nTEST ASKED AAROGYAM FULL BODY CHECKUP WITH VITAMINS - \nNEW, FREE TESTOSTERONE:\n:\n:K 1902 BRIGADE METROPOLIS \nGARUDACHARYAPALYA MAHADEVPURA \nMAHDEVPURA WHITEFIELD RD BENGALURUHOME COLLECTION :\nTEST NAME UNITS VALUE TECHNOLOGY \nHIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 0.8\nReference Range :-mg/L\n< 1.00         -  Low Risk\n1.00 - 3.00    -  Average Risk\n>3.00 - 10.00  -  High Risk\n> 10.00        -  Possibly due to Non -Cardiac Inflammation\nDisclaimer:  Persistent unexplained elevation of HSCRP >10 should be evaluated for non -cardiovascular etiologies such as infection , \nactive arthritis or concurrent illness . \nClinical significance:\nHigh sensitivity C - reactive Protein ( HSCRP) can be used as an independent risk marker for the identification of Individuals at risk for \nfuture cardiovascular Disease . A coronary artery disease risk assessment should be based on the average of two hs -CRP tests, ideally \ntaken two weeks apart .\nKit Validation Reference :\n1.Clinical management of laboratory date in medical practice 2003-3004, 207(2003). \n2.Tietz : Textbook of Clinical Chemistry and Molecular diagnostics :Second edition :Chapter 47: Page no .1507- 1508.\nPlease correlate with clinical conditions.\nMethod:- FULLY AUTOMATED LATEX AGGLUTINATION ‚Äì BECKMAN COULTER\nSERUM05 Aug 2023 15:1505 Aug 2023 12:30:\n:\n:\n:Sample TypeReport  Released on (RRT)Sample Received on (SRT)\nBE329513:Barcode:0508040464/DG007 Labcode\nPage : 3 of 14Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD (Path)\nSample Collected on (SCT) 05 Aug 2023 08:13\nNote:- Underlined values are Critical Values , Clinician''s attention required. Clinically Tested by :Thyrocare Technologies Ltd\n\n--- Page Break ---\nNAME  \nSELFAMAN ANKUR(31Y/M)\nREF. BY\nTEST ASKED AAROGYAM FULL BODY CHECKUP WITH VITAMINS - \nNEW, FREE TESTOSTERONE:\n:\n:K 1902 BRIGADE METROPOLIS \nGARUDACHARYAPALYA MAHADEVPURA \nMAHDEVPURA WHITEFIELD RD BENGALURUHOME COLLECTION :\nTEST NAME UNITS VALUE TECHNOLOGY \nLipoprotein (a) [Lp(a)] IMMUNOTURBIDIMETRY 14.4\nReference Range :-mg/dL\nAdults :  < 30.0 mg/dl\nClinical Significance:\nDetermination of LPA may be useful to guide management of individuals with a family history of CHD or with existing disease . The \nlevels of LPA in the blood depends on genetic factors ; The range of variation in a population is relatively large and hence for diagnostic \npurpose, results should always be assessed in conjunction with the patient‚Äôs medical history , clinical examination and other findings.\nSpecifications:\nPrecision %CV :- Intra assay %CV- 4.55% , Inter assay %CV-0.86 %\nKit Validation Reference :\nTietz NW, Clinical Guide to Laboratory Tests Philadelphia  WB . Saunders 1995 : 442-444\nPlease correlate with clinical conditions.\nMethod:- LATEX ENHANCED IMMUNOTURBIDIMETRY\nSERUM05 Aug 2023 15:1505 Aug 2023 12:30:\n:\n:\n:Sample TypeReport  Released on (RRT)Sample Received on (SRT)\nBE329513:Barcode:0508040464/DG007 Labcode\nPage : 4 of 14Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD (Path)\nSample Collected on (SCT) 05 Aug 2023 08:13\nNote:- Underlined values are Critical Values , Clinician''s attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)\n\n--- Page Break ---\nNAME  \nSELFAMAN ANKUR(31Y/M)\nREF. BY\nTEST ASKED AAROGYAM FULL BODY CHECKUP WITH VITAMINS - \nNEW, FREE TESTOSTERONE:\n:\n:K 1902 BRIGADE METROPOLIS \nGARUDACHARYAPALYA MAHADEVPURA \nMAHDEVPURA WHITEFIELD RD BENGALURUHOME COLLECTION :\nTEST NAME TECHNOLOGY VALUE UNITS\n68.69 PHOTOMETRY ¬µg/dL IRON\nMale : 65 - 175\nFemale : 50 - 170Reference Range :\nMethod : FERROZINE METHOD WITHOUT DEPROTEINIZATION\n377.69 PHOTOMETRY ¬µg/dL TOTAL IRON BINDING CAPACITY (TIBC)\nMale: 225 - 535 ¬µg/dl  Female: 215 - 535 ¬µg/dlReference Range :\nMethod : SPECTROPHOTOMETRIC ASSAY\n18.19 CALCULATED % % TRANSFERRIN SATURATION\n13 - 45Reference Range :\nMethod : DERIVED FROM IRON AND TIBC VALUES\n309 PHOTOMETRY ¬µg/dL UNSAT.IRON-BINDING CAPACITY(UIBC)\n162 - 368Reference Range :\nMethod : SPECTROPHOTOMETRIC ASSAY\nPlease correlate with clinical conditions. \nSERUM05 Aug 2023 15:1505 Aug 2023 12:3005 Aug 2023 08:13 :\n:\n:\n: Sample TypeReport  Released on (RRT)Sample Received on (SRT)\nBE329513: Barcode:0508040464/DG007 Labcode\nPage : 5 of 14Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD (Path)\nSample Collected on (SCT)\nNote:- Underlined values are Critical Values , Clinician''s attention required. Clinically Tested by :Thyrocare Technologies Ltd\n\n--- Page Break ---\nNAME\nSELFAMAN ANKUR(31Y/M)\nREF. BY\nTEST ASKED AAROGYAM FULL BODY CHECKUP WITH VITAMINS - \nNEW, FREE TESTOSTERONE:\n:\n:K 1902 BRIGADE METROPOLIS GARUDACHARYAPALYA \nMAHADEVPURA MAHDEVPURA WHITEFIELD RD \nBENGALURUHOME COLLECTION :\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\nALKALINE PHOSPHATASE PHOTOMETRY 45-129 U/L  88.09\nBILIRUBIN - TOTAL PHOTOMETRY 0.3-1.2 mg/dL  0.48\nBILIRUBIN -DIRECT PHOTOMETRY < 0.3 mg/dL  0.1\nBILIRUBIN (INDIRECT) CALCULATED 0-0.9 mg/dL  0.38\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY < 55 U/L  22.4\nSGOT / SGPT RATIO CALCULATED < 2 Ratio  0.78\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY < 35 U/L  33.3\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY < 45 U/L  42.6\nPROTEIN - TOTAL PHOTOMETRY 5.7-8.2 gm/dL  7.73\nALBUMIN - SERUM PHOTOMETRY 3.2-4.8 gm/dL  4.77\nSERUM GLOBULIN CALCULATED 2.5-3.4 gm/dL  2.96\nSERUM ALB/GLOBULIN RATIO CALCULATED 0.9 - 2 Ratio  1.61\nPlease correlate with clinical conditions.\nMethod :\nALKP - MODIFIED IFCC METHOD\nBILT - VANADATE OXIDATION\nBILD - VANADATE OXIDATION\nBILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES\nGGT - MODIFIED IFCC METHOD\nOT/PT - Derived from SGOT and SGPT values .\nSGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\nSGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION\nPROT -   BIURET METHOD\nSALB - ALBUMIN BCG¬πMETHOD ( COLORIMETRIC ASSAY ENDPOINT )\nSEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\nA/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES\nPage : 6 of 14SERUM05 Aug 2023 15:1505 Aug 2023 12:3005 Aug 2023 08:13\n:\n:\n:Sample TypeReport  Released on (RRT)Sample Received on (SRT)Sample Collected on (SCT)\nBE329513: Barcode:0508040464/DG007 Labcode Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD (Path)\nNote:- Underlined values are Critical Values , Clinician''s attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)\n:\n--- Page Break ---\nNAME\nSELFAMAN ANKUR(31Y/M)\nREF. BY\nTEST ASKED AAROGYAM FULL BODY CHECKUP WITH VITAMINS - \nNEW, FREE TESTOSTERONE:\n:\n:K 1902 BRIGADE METROPOLIS GARUDACHARYAPALYA \nMAHADEVPURA MAHDEVPURA WHITEFIELD RD \nBENGALURUHOME COLLECTION :\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\nUREA (CALCULATED) CALCULATED Adult : 17-43 mg/dL  32.53\nBLOOD UREA NITROGEN (BUN) PHOTOMETRY 7.94 - 20.07 mg/dL  15.2\nUREA / SR.CREATININE RATIO CALCULATED < 52 Ratio  36.55\nCREATININE - SERUM PHOTOMETRY 0.72-1.18 mg/dL  0.89\nBUN / SR.CREATININE RATIO CALCULATED 9:1-23:1 Ratio  17.08\nCALCIUM PHOTOMETRY 8.8-10.6 mg/dL  10.1\nURIC ACID PHOTOMETRY 4.2 - 7.3 mg/dL  5.98\nSODIUM I.S.E 136 - 145 mmol/L  138\nCHLORIDE I.S.E 98 - 107 mmol/L  100\nPlease correlate with clinical conditions.\nMethod :\nUREAC - Derived from BUN Value .\nBUN - KINETIC UV ASSAY .\nUR/CR - Derived from UREA and Sr .Creatinine values .\nSCRE - CREATININE ENZYMATIC METHOD\nB/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES\nCALC - ARSENAZO III METHOD , END POINT.\nURIC - URICASE / PEROXIDASE METHOD\nSOD - ION SELECTIVE ELECTRODE\nCHL - ION SELECTIVE ELECTRODE\nPage : 7 of 14SERUM05 Aug 2023 15:1505 Aug 2023 12:3005 Aug 2023 08:13\n:\n:\n:Sample TypeReport  Released on (RRT)Sample Received on (SRT)Sample Collected on (SCT)\nBE329513: Barcode:0508040464/DG007 Labcode Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD (Path)\nNote:- Underlined values are Critical Values , Clinician''s attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)\n:\n--- Page Break ---\nNAME  \nREF. BY\nTEST ASKEDK 1902 BRIGADE METROPOLIS GARUDACHARYAPALYA \nMAHADEVPURA MAHDEVPURA WHITEFIELD RD \nBENGALURU :::\nAAROGYAM FULL BODY CHECKUP WITH VITAMINS - \nNEW, FREE TESTOSTERONESELFAMAN ANKUR(31Y/M) HOME COLLECTION :\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\nTOTAL TRIIODOTHYRONINE (T3) E.C.L.I.A ng/dL 80-200 111\nTOTAL THYROXINE (T4) E.C.L.I.A ¬µg/dL 4.8-12.7 8.54\nTSH - ULTRASENSITIVE E.C.L.I.A ¬µIU/mL 0.54-5.30 3.02\nComments :\nPlease correlate with clinical conditions.\nMethod :\nT3 - Fully Automated Electrochemiluminescence Compititive Immunoassay\nT4 - Fully Automated Electrochemiluminescence Compititive Immunoassay\nUSTSH - Fully Automated Electrochemiluminescence Sandwich Immunoassay***\nSample TypeReport  Released on (RRT)Sample Received on (SRT)\nBarcodeLabcode:\n:\n:\n:\n:\n:05 Aug 2023 12:30\n05 Aug 2023 15:15\nSERUM\n0508040464/DG007\nBE329513\nDr Syeda Sumaiya MD(Path)\n Dr.Ashwin Mathew MD (Path)\nPage : 8 of 1405 Aug 2023 08:13 Sample Collected on (SCT)\nNote:- Underlined values are Critical Values , Clinician''s attention required. Clinically Tested by :Thyrocare Technologies Ltd\n\n--- Page Break ---\nNAME  \nSELFAMAN ANKUR(31Y/M)\nREF. BY\nTEST ASKED AAROGYAM FULL BODY CHECKUP WITH VITAMINS - \nNEW, FREE TESTOSTERONE:\n:\n:K 1902 BRIGADE METROPOLIS \nGARUDACHARYAPALYA MAHADEVPURA \nMAHDEVPURA WHITEFIELD RD BENGALURUHOME COLLECTION :\nTEST NAME UNITS VALUE TECHNOLOGY \nEST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 114\nReference Range :-mL/min/1.73 m2\n>  =  90 : Normal\n60 - 89 : Mild Decrease\n45 - 59 : Mild to Moderate Decrease\n30 - 44 : Moderate to Severe Decrease\n15 - 29 : Severe Decrease\nClinical Significance\nThe normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient . Because mild and moderate \nkidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely estimate \nglomerular filtration rate (eGFR), a ‚Äúgold standard‚Äù measurement for assessment of renal function, and report the value when serum \ncreatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in clinical practice , \ninstead, GFR is estimated from equations using serum creatinine, age, race and sex . This provides easy to interpret information for the \ndoctor and patient on the degree of renal impairment since it approximately equates to the percentage of kidney function remaining . \nApplication of CKD- EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and \nmanagement of patients with CKD.\nReference \nLevey AS , Stevens LA , Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI , et al. A new equation to estimate glomerular filtration rate . \nAnn Intern Med. 2009;150(9):604-12.\nPlease correlate with clinical conditions.\nMethod:- CKD-EPI Creatinine Equation\nSERUM05 Aug 2023 15:1505 Aug 2023 12:30:\n:\n:\n:Sample TypeReport  Released on (RRT)Sample Received on (SRT)\nBE329513:Barcode:0508040464/DG007 Labcode\nPage : 9 of 14Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD (Path)\nSample Collected on (SCT) 05 Aug 2023 08:13\nNote:- Underlined values are Critical Values , Clinician''s attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)\n\n--- Page Break ---\nNAME\nSELFAMAN ANKUR(31Y/M)\nREF. BY\nTEST ASKED AAROGYAM FULL BODY CHECKUP WITH VITAMINS - \nNEW, FREE TESTOSTERONE:\n:\n:K 1902 BRIGADE METROPOLIS GARUDACHARYAPALYA \nMAHADEVPURA MAHDEVPURA WHITEFIELD RD \nBENGALURUHOME COLLECTION :\nTEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE\nTOTAL CHOLESTEROL PHOTOMETRY < 200 mg/dL  249\nHDL CHOLESTEROL - DIRECT PHOTOMETRY 40-60 mg/dL  37\nHDL / LDL RATIO CALCULATED > 0.40 Ratio  0.21\nLDL CHOLESTEROL - DIRECT PHOTOMETRY < 100 mg/dL  177\nTRIGLYCERIDES PHOTOMETRY < 150 mg/dL  232\nTC/ HDL CHOLESTEROL RATIO CALCULATED 3 - 5 Ratio  6.6\nLDL / HDL RATIO CALCULATED 1.5-3.5 Ratio  4.7\nVLDL CHOLESTEROL CALCULATED 5 - 40 mg/dL  46.46\nNON-HDL CHOLESTEROL CALCULATED < 160 mg/dL  211.1\nTRIG / HDL RATIO CALCULATED < 3.12 Ratio  6.21\nPlease correlate with clinical conditions.\nMethod :\nCHOL - CHOLESTEROL OXIDASE , ESTERASE , PEROXIDASE\nHCHO - DIRECT ENZYMATIC COLORIMETRIC\nHD/LD - Derived from HDL and LDL values .\nLDL - DIRECT MEASURE\nTRIG - ENZYMATIC , END POINT\nTC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\nLDL/ - DERIVED FROM SERUM HDL AND LDL VALUES\nVLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES\nNHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES\nTRI/H - Derived from TRIG and HDL Values\nAlert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:\nTOTAL CHOLESTEROL   \n>190 VERY HIGH                 >500 VERY HIGH                 160-189 HIGH                         200-499 HIGH                        130-159 BORDERLINE HIGH   >240 HIGH                              150-199 BORDERLINE HIGH    100-129 NEAR OPTIMAL          >60 HIGH          200-239 BORDERLINE HIGH            <150NORMAL                   <100OPTIMAL                    <40 LOW             <200 DESIRABLE                      (mg/dl) TRIGLYCERIDES   (mg/dl)LDL                          (mg/dl) HDL           (mg/dl)\nPage : 10 of 14SERUM05 Aug 2023 15:1505 Aug 2023 12:3005 Aug 2023 08:13\n:\n:\n:Sample TypeReport  Released on (RRT)Sample Received on (SRT)Sample Collected on (SCT)\nBE329513: Barcode:0508040464/DG007 Labcode Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD (Path)\nNote:- Underlined values are Critical Values , Clinician''s attention required. Clinically Tested by :Thyrocare Technologies Ltd\n:\n--- Page Break ---\nNAME  \nSELFAMAN ANKUR(31Y/M)\nREF. BY\nTEST ASKED AAROGYAM FULL BODY CHECKUP WITH VITAMINS - \nNEW, FREE TESTOSTERONE:\n:\n:K 1902 BRIGADE METROPOLIS \nGARUDACHARYAPALYA MAHADEVPURA \nMAHDEVPURA WHITEFIELD RD BENGALURUHOME COLLECTION :\nTEST NAME UNITS VALUE TECHNOLOGY \nFASTING BLOOD SUGAR(GLUCOSE) PHOTOMETRY 92 mg/dL\nNormal  As per ADA Guideline: Fasting Plasma Glucose (FPG)\n70 to 100 mg/dl\nPrediabetes 100 mg/dl to 125 mg/dl\nDiabetes 126 mg/dl or higherReference Range :-\nNote : \nThe assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies , hemolyzed , \nicteric or lipemic. The concentration of Glucose in a given specimen may vary due to differences in assay methods , calibration and \nreagent specificity . For diagnostic purposes results should always be assessed in conjunction with patients medical history , clinical \nfindings and other findings.\nPlease correlate with clinical conditions.\nMethod:- GOD-PAP METHOD\nFLUORIDE05 Aug 2023 13:3005 Aug 2023 12:22:\n:\n:\n:Sample TypeReport  Released on (RRT)Sample Received on (SRT)\nBG422783:Barcode:0508071179/DG007 Labcode\nPage : 11 of 14Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD (Path)\nSample Collected on (SCT) 05 Aug 2023 08:13\nNote:- Underlined values are Critical Values , Clinician''s attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)\n\n--- Page Break ---\nNAME  \nSELFAMAN ANKUR(31Y/M)\nREF. BY\nTEST ASKED AAROGYAM FULL BODY CHECKUP WITH VITAMINS - \nNEW, FREE TESTOSTERONE:\n:\n:K 1902 BRIGADE METROPOLIS \nGARUDACHARYAPALYA MAHADEVPURA \nMAHDEVPURA WHITEFIELD RD BENGALURUHOME COLLECTION :\nTEST NAME TECHNOLOGY VALUE UNITS\nHbA1c - (HPLC)\n5.1 H.P.L.C %\nBelow 5.7%   : Normal\n5.7% - 6.4% : Prediabetic\n>=6.5%        : Diabetic   Reference Range: As per ADA Guidelines\nBelow 6.5% : Good Control\n6.5% - 7%  : Fair Control\n7.0% - 8%  : Unsatisfactory Control\n>8%           : Poor ControlGuidance For Known DiabeticsReference Range :\nMethod : Fully Automated H.P.L.C method\n100 CALCULATED mg/dL AVERAGE BLOOD GLUCOSE (ABG)\n90 - 120 mg/dl   : Good Control\n121 - 150 mg/dl : Fair Control\n151 - 180 mg/dl : Unsatisfactory Control\n> 180 mg/dl      : Poor ControlReference Range :\nMethod : Derived from HBA1c  values\nPlease correlate with clinical conditions. \nEDTA05 Aug 2023 13:5105 Aug 2023 12:2105 Aug 2023 08:13 :\n:\n:\n: Sample TypeReport  Released on (RRT)Sample Received on (SRT)\nBH845818: Barcode:0508071058/DG007 Labcode\nPage : 12 of 14Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD (Path)\nSample Collected on (SCT)\nNote:- Underlined values are Critical Values , Clinician''s attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)\n\n--- Page Break ---\nNAME  \nSELFAMAN ANKUR(31Y/M)\nREF. BY\nTEST ASKED AAROGYAM FULL BODY CHECKUP WITH VITAMINS - \nNEW, FREE TESTOSTERONE:\n:\n:K 1902 BRIGADE METROPOLIS \nGARUDACHARYAPALYA MAHADEVPURA \nMAHDEVPURA WHITEFIELD RD BENGALURUHOME COLLECTION :\nTEST NAME VALUE UNITS REFERENCE RANGE\nX 10¬≥ / ¬µL  9.86 4.0 - 10.0 TOTAL LEUCOCYTES COUNT (WBC)\n%  61.5 40-80 NEUTROPHILS\n%  26.6 20-40 LYMPHOCYTE\n%  3.5 2-10 MONOCYTES\n%  7.6 1-6 EOSINOPHILS\n%  0.5 0-2 BASOPHILS\n%  0.3 0-0.5 IMMATURE GRANULOCYTE PERCENTAGE(IG%)\nX 10¬≥ / ¬µL  6.06 2.0-7.0 NEUTROPHILS - ABSOLUTE COUNT\nX 10¬≥ / ¬µL  2.62 1.0-3.0 LYMPHOCYTES - ABSOLUTE COUNT\nX 10¬≥ / ¬µL  0.35 0.2 - 1.0 MONOCYTES - ABSOLUTE COUNT\nX 10¬≥ / ¬µL  0.05 0.02 - 0.1 BASOPHILS - ABSOLUTE COUNT\nX 10¬≥ / ¬µL  0.75 0.02 - 0.5 EOSINOPHILS - ABSOLUTE COUNT\nX 10¬≥ / ¬µL  0.03 0-0.3 IMMATURE GRANULOCYTES(IG)\nX 10^6/¬µL  5.42 4.5-5.5 TOTAL RBC\nX 10¬≥ / ¬µL  0.01 0.0-0.5 NUCLEATED RED BLOOD CELLS\n%  0.01 0.0-5.0 NUCLEATED RED BLOOD CELLS %\ng/dL  15.9 13.0-17.0 HEMOGLOBIN\n%  48 40.0-50.0 HEMATOCRIT(PCV)\nfL  88.6 83.0-101.0 MEAN CORPUSCULAR VOLUME(MCV)\npq  29.3 27.0-32.0 MEAN CORPUSCULAR HEMOGLOBIN(MCH)\ng/dL  33.1 31.5-34.5 MEAN CORP.HEMO.CONC(MCHC)\nfL  41.9 39-46 RED CELL DISTRIBUTION WIDTH - SD(RDW-SD)\n%  12.9 11.6-14 RED CELL DISTRIBUTION WIDTH (RDW-CV)\nfL  12.3 9.6-15.2 PLATELET DISTRIBUTION WIDTH(PDW)\nfL  10.4 6.5-12 MEAN PLATELET VOLUME(MPV)\nX 10¬≥ / ¬µL  320 150-410 PLATELET COUNT\n%  28.1 19.7-42.4 PLATELET TO LARGE CELL RATIO(PLCR)\n%  0.33 0.19-0.39 PLATELETCRIT(PCT)\nAlert!!!  Predominantly normocytic normochromic with ovalocytes.  Platelets:Appear adequate in smear. Remarks : \nMethod : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)\n(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow \nCytometry Method (using a semiconductor laser), and SLS- hemoglobin method)Please Correlate with clinical conditions.\nEDTA05 Aug 2023 13:5105 Aug 2023 12:21:\n:\n:\n: Sample TypeReport  Released on (RRT)Sample Received on (SRT)\nBH845818: Barcode:0508071058/DG007Labcode\nPage : 13 of 14Dr.Ashwin Mathew MD (Path)\n Dr Syeda Sumaiya MD(Path)Sample Collected on (SCT) 05 Aug 2023 08:13\nNote:- Underlined values are Critical Values , Clinician''s attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)\n\n--- Page Break ---\nNAME  \nSELFAMAN ANKUR(31Y/M)\nREF. BY\nTEST ASKED AAROGYAM FULL BODY CHECKUP WITH VITAMINS - \nNEW, FREE TESTOSTERONE:\n:\n:K 1902 BRIGADE METROPOLIS \nGARUDACHARYAPALYA MAHADEVPURA MAHDEVPURA \nWHITEFIELD RD BENGALURUHOME COLLECTION :\nTEST NAME OBSERVATION REFERENCE RANGE\nComplete UrinogramUNITS\nPhysical Examination\nVOLUME 3 - mL\nCOLOUR PALE YELLOW Pale Yellow -\nAPPEARANCE CLEAR Clear -\nSPECIFIC GRAVITY 1.02 1.003-1.030 -\nPH 5.5 5-8 -\nChemical Examination\nURINARY PROTEIN ABSENT Absent mg/dL\nURINARY GLUCOSE ABSENT Absent mg/dL\nURINE KETONE ABSENT Absent mg/dL\nURINARY BILIRUBIN ABSENT Absent mg/dL\nUROBILINOGEN Normal <=0.2 mg/dL\nBILE SALT ABSENT Absent -\nBILE PIGMENT ABSENT Absent -\nURINE BLOOD ABSENT Absent -\nNITRITE ABSENT Absent -\nMICROALBUMIN 10 < 30 mg/L\nMicroscopic Examination\nMUCUS ABSENT Absent -\nRED BLOOD CELLS ABSENT 0-5 cells/HPF\nURINARY LEUCOCYTES (PUS CELLS) ABSENT 0-5 cells/HPF\nEPITHELIAL CELLS ABSENT 0-5 cells/HPF\nCASTS ABSENT Absent -\nCRYSTALS ABSENT Absent -\nBACTERIA ABSENT Absent -\nYEAST ABSENT Absent -\nPARASITE ABSENT Absent -\nMethod : Fully Automated DIRUI FUS2000 Urinalysis Dipstick Method, Microscopy\n~~ End of report ~~\nURINE05 Aug 2023 13:3405 Aug 2023 12:3505 Aug 2023 08:13 :\n:\n:\n:Sample Collected on (SCT)\nSample Received on (SRT)\nReport  Released on (RRT)\nSample Type\nBI960350: Barcode:0508072019/DG007 Labcode\nPage : 14 of 14\nNote:- Underlined values are Critical Values , Clinician''s attention required. Clinically Tested by :Thyrocare Technologies Ltd - (NABL accredited)\nDr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD (Path)','\n',char(10)),'processed',NULL,'212c0a9391fc4fde9be25eca648133ab','Thyrocare Technologies Ltd.','AMAN ANKUR',NULL,31,'M',NULL,0.974358974358974339);
CREATE TABLE biomarkers (
	id INTEGER NOT NULL, 
	pdf_id INTEGER, 
	profile_id CHAR(32), 
	name VARCHAR, 
	original_name VARCHAR, 
	original_value VARCHAR, 
	original_unit VARCHAR, 
	value FLOAT, 
	unit VARCHAR, 
	reference_range_low FLOAT, 
	reference_range_high FLOAT, 
	reference_range_text VARCHAR, 
	category VARCHAR, 
	is_abnormal BOOLEAN, 
	importance INTEGER, 
	extracted_date DATETIME, 
	validated BOOLEAN, 
	validated_by VARCHAR, 
	validated_date DATETIME, 
	notes TEXT, 
	PRIMARY KEY (id), 
	FOREIGN KEY(pdf_id) REFERENCES pdfs (id), 
	FOREIGN KEY(profile_id) REFERENCES profiles (id)
);
INSERT INTO biomarkers VALUES(1,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Hemoglobin','HEMOGLOBIN(HB)','15.0','g/dL',15.0,'g/dL',13.0,17.0,'13.0 - 17.0','Blood',0,1,'2025-04-01 11:58:24.319665',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(2,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Red Blood Cell Count','REDBLOODCELL(RBC)COUNT','5.28','mil/¬µL',5.280000000000000248,'mil/¬µL',4.5,5.5,'4.5 - 5.5','Blood',0,1,'2025-04-01 11:58:24.319669',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(3,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','White Blood Cell Count','WHITEBLOODCELL(WBC)COUNT','9.23','thou/¬µL',9.23000000000000042,'thou/¬µL',4.0,10.0,'4.0 - 10.0','Blood',0,1,'2025-04-01 11:58:24.319670',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(4,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Platelet Count','PLATELETCOUNT','348','thou/¬µL',348.0,'thou/¬µL',150.0,410.0,'150 - 410','Blood',0,1,'2025-04-01 11:58:24.319671',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(5,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Hematocrit','HEMATOCRIT(PCV)','45.0','%',45.0,'%',40.0,50.0,'40 - 50','Blood',0,1,'2025-04-01 11:58:24.319672',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(6,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Mean Corpuscular Volume','MEANCORPUSCULARVOLUME(MCV)','85.28','fL',85.28000000000000113,'fL',83.0,101.0,'83.0 - 101.0','Blood',0,1,'2025-04-01 11:58:24.319673',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(7,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Mean Corpuscular Hemoglobin','MEANCORPUSCULARHEMOGLOBIN(MCH)','28.4','pg',28.39999999999999858,'pg',27.0,32.0,'27.0 - 32.0','Blood',0,1,'2025-04-01 11:58:24.319674',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(8,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Mean Corpuscular Hemoglobin Concentration','MEANCORPUSCULARHEMOGLOBINCONCENTRATION(MCHC)','33.3','g/dL',33.29999999999999715,'g/dL',31.5,34.5,'31.5 - 34.5','Blood',0,1,'2025-04-01 11:58:24.319675',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(9,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Red Cell Distribution Width','REDCELLDISTRIBUTIONWIDTH(RDW)','13.8','%',13.80000000000000071,'%',11.59999999999999965,14.0,'11.6 - 14.0','Blood',0,1,'2025-04-01 11:58:24.319677',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(10,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Mean Platelet Volume','MEANPLATELETVOLUME(MPV)','9.6','fL',9.59999999999999965,'fL',6.799999999999999823,10.90000000000000035,'6.8 - 10.9','Blood',0,1,'2025-04-01 11:58:24.319678',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(11,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Neutrophils','NEUTROPHILS','64','%',64.0,'%',40.0,80.0,'40 - 80','Blood',0,1,'2025-04-01 11:58:24.319679',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(12,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Lymphocytes','LYMPHOCYTES','26','%',26.0,'%',20.0,40.0,'20 - 40','Blood',0,1,'2025-04-01 11:58:24.319680',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(13,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Monocytes','MONOCYTES','7','%',7.0,'%',2.0,10.0,'2 - 10','Blood',0,1,'2025-04-01 11:58:24.319681',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(14,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Eosinophils','EOSINOPHILS','3','%',3.0,'%',1.0,6.0,'1 - 6','Blood',0,1,'2025-04-01 11:58:24.319682',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(15,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Basophils','BASOPHILS','0','%',0.0,'%',NULL,1.0,'< 1 - 2','Blood',0,1,'2025-04-01 11:58:24.319682',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(16,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Absolute Neutrophil Count','ABSOLUTENEUTROPHILCOUNT','5.91','thou/¬µL',5.910000000000000142,'thou/¬µL',2.0,7.0,'2.0 - 7.0','Blood',0,1,'2025-04-01 11:58:24.319683',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(17,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Absolute Lymphocyte Count','ABSOLUTELYMPHOCYTECOUNT','2.40','thou/¬µL',2.399999999999999912,'thou/¬µL',1.0,3.0,'1.0 - 3.0','Blood',0,1,'2025-04-01 11:58:24.319684',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(18,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Absolute Monocyte Count','ABSOLUTEMONOCYTECOUNT','0.65','thou/¬µL',0.6500000000000000222,'thou/¬µL',0.2000000000000000111,1.0,'0.2 - 1.0','Blood',0,1,'2025-04-01 11:58:24.319685',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(19,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Absolute Eosinophil Count','ABSOLUTEEOSINOPHILCOUNT','0.28','thou/¬µL',0.2800000000000000267,'thou/¬µL',0.02000000000000000041,0.5,'0.02 - 0.50','Blood',0,1,'2025-04-01 11:58:24.319686',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(20,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Absolute Basophil Count','ABSOLUTEBASOPHILCOUNT','0.00','thou/¬µL',0.0,'thou/¬µL',0.0,0.1000000000000000055,'0.0 - 0.1','Blood',0,1,'2025-04-01 11:58:24.319687',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(21,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Glycosylated Hemoglobin','HBA1C','5.6','%',5.599999999999999645,'%',NULL,5.700000000000000177,'Non-diabetic Adult < 5.7 Pre-diabetes 5.7 - 6.4 Diabetes diagnosis: > or = 6.5 Therapeutic goals: < 7.0 Action suggested : > 8.0','Metabolic',0,1,'2025-04-01 11:58:24.319688',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(22,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Estimated Average Glucose','ESTIMATEDAVERAGEGLUCOSE(EAG)','114.0','mg/dL',114.0,'mg/dL',NULL,116.0,'< 116.0','Metabolic',0,1,'2025-04-01 11:58:24.319689',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(23,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Fasting Blood Sugar','FBS(FASTINGBLOODSUGAR)','95','mg/dL',95.0,'mg/dL',NULL,100.0,'Normal <100, Impaired fasting glucose:100 to 125, Diabetes mellitus:>=126 (on more than 1 occasion)','Metabolic',0,1,'2025-04-01 11:58:24.319689',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(24,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Total Bilirubin','BILIRUBIN,TOTAL','0.49','mg/dL',0.4899999999999999912,'mg/dL',NULL,1.199999999999999956,'Upto 1.2','Liver',0,1,'2025-04-01 11:58:24.319690',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(25,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Direct Bilirubin','BILIRUBIN,DIRECT','0.25','mg/dL',0.25,'mg/dL',NULL,0.2999999999999999889,'<= 0.3','Liver',0,1,'2025-04-01 11:58:24.319691',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(26,1,'3edc5fb9c2fa48b2a66a2be1b8c7f9d4','Indirect Bilirubin','BILIRUBIN,INDIRECT','0.24','mg/dL',0.2399999999999999912,'mg/dL',0.1000000000000000055,1.0,'0.1 - 1.0','Liver',0,1,'2025-04-01 11:58:24.319692',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(27,2,'212c0a9391fc4fde9be25eca648133ab','Free Testosterone','Testosterone - Free Serum , ELISA','13.01','pg/mL',13.00999999999999979,'pg/mL',5.009999999999999787,27.78000000000000113,'5.01-27.78','Hormone',0,1,'2025-04-01 12:00:07.028673',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(28,4,'6943fda865cf4031806a4e03190d18e4','Creatinine','CREATININE, SERUM','1.35','mg/dL',1.350000000000000088,'mg/dL',0.5999999999999999778,1.199999999999999956,'0.6 - 1.2','Kidney',1,1,'2025-04-01 12:24:01.685604',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(29,4,'6943fda865cf4031806a4e03190d18e4','Uric Acid','URIC ACID, SERUM','5.4','mg/dL',5.419999999999999929,'mg/dL',2.5,6.799999999999999823,'2.5 - 6.8','Metabolic',0,1,'2025-04-01 12:24:01.685609',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(30,4,'6943fda865cf4031806a4e03190d18e4','Glucose','GLUCOSE FASTING,FLUORIDE PLASMA','121','mg/dL',121.0,'mg/dL',NULL,100.0,'Normal <100,Impaired fasting glucose:100 to 125,Diabetes mellitus:>=126(on more than 1 occasion)(ADA guidelines 2024)','Metabolic',1,1,'2025-04-01 12:24:01.685610',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(31,5,'212c0a9391fc4fde9be25eca648133ab','Glucose','Fasting Glucose','85','mg/dL',85.0,'mg/dL',70.0,99.0,'70-99 mg/dL','Metabolic',0,1,'2025-04-01 12:41:36.208212',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(32,5,'212c0a9391fc4fde9be25eca648133ab','Total Bilirubin','Serum Total Bilirubin','0.65','mg/dL',0.6500000000000000222,'mg/dL',0.2000000000000000111,1.300000000000000044,'Adult: 0.2-1.3 mg/dL','Liver',0,1,'2025-04-01 12:41:36.208219',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(33,5,'212c0a9391fc4fde9be25eca648133ab','Direct Bilirubin','Direct Bilirubin','0.33','mg/dL',0.3300000000000000155,'mg/dL',NULL,NULL,'Neonate: 0.0-0.6 mg/dL, Adult: 0.0-0.3 mg/dL','Liver',1,1,'2025-04-01 12:41:36.208220',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(34,5,'212c0a9391fc4fde9be25eca648133ab','Indirect Bilirubin','Indirect Bilirubin','0.32','mg/dL',0.3200000000000000066,'mg/dL',NULL,NULL,'Adult: 0.1-1.1 mg/dL, Neonate: 0.6-10.5 mg/dL','Liver',0,1,'2025-04-01 12:41:36.208221',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(35,5,'212c0a9391fc4fde9be25eca648133ab','Aspartate Aminotransferase','Aspartate Transaminase(AST/ SGOT)','26','U/L',26.0,'U/L',17.0,49.0,'17-49 U/L','Liver',0,1,'2025-04-01 12:41:36.208223',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(36,5,'212c0a9391fc4fde9be25eca648133ab','Alanine Aminotransferase','Alanine Transaminase(ALT/ SGPT)','30','U/L',30.0,'U/L',NULL,50.0,'< 50 U/L','Liver',0,1,'2025-04-01 12:41:36.208224',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(37,5,'212c0a9391fc4fde9be25eca648133ab','Alkaline Phosphatase','Alkaline Phosphatase','70','U/L',70.0,'U/L',38.0,126.0,'38-126 U/L','Liver',0,1,'2025-04-01 12:41:36.208225',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(38,5,'212c0a9391fc4fde9be25eca648133ab','Gamma-Glutamyl Transferase','Gamma-Glutamyl Transferase (GGT)','17','U/L',17.0,'U/L',15.0,73.0,'15-73 U/L','Liver',0,1,'2025-04-01 12:41:36.208226',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(39,5,'212c0a9391fc4fde9be25eca648133ab','Total Protein','Total Protein','7.2','g/dL',7.200000000000000177,'g/dL',6.0,8.300000000000000711,'6.0-8.3 g/dL','Liver',0,1,'2025-04-01 12:41:36.208227',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(40,5,'212c0a9391fc4fde9be25eca648133ab','Albumin','Albumin','4.4','g/dL',4.400000000000000356,'g/dL',3.5,5.0,'3.5-5.0 g/dL','Liver',0,1,'2025-04-01 12:41:36.208228',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(41,5,'212c0a9391fc4fde9be25eca648133ab','Globulin','Globulin','2.7','g/dL',2.700000000000000177,'g/dL',2.299999999999999822,3.5,'2.3-3.5 g/dL','Liver',0,1,'2025-04-01 12:41:36.208229',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(42,5,'212c0a9391fc4fde9be25eca648133ab','Albumin/Globulin Ratio','A/G ratio','1.6','ratio',1.600000000000000088,'ratio',0.8000000000000000444,2.0,'0.8-2.0','Liver',0,1,'2025-04-01 12:41:36.208231',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(43,5,'212c0a9391fc4fde9be25eca648133ab','AST/ALT Ratio','SGOT/SGPT- RATIO','0.9','ratio',0.9000000000000000222,'ratio',0.6999999999999999556,1.399999999999999912,'0.7-1.4','Liver',0,1,'2025-04-01 12:41:36.208232',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(44,6,'212c0a9391fc4fde9be25eca648133ab','Glucose','Glucose, Fasting','81','mg/dL',81.0,'mg/dL',70.0,99.0,'70-99 mg/dL','Metabolic',0,1,'2025-04-01 17:30:01.860635',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(45,6,'212c0a9391fc4fde9be25eca648133ab','Total Bilirubin','Serum Total Bilirubin','0.8','mg/dL',0.8000000000000000444,'mg/dL',NULL,NULL,'Adult: 0.2-1.3, Neonate: 1.0-10.5','Liver',0,1,'2025-04-01 17:30:01.860640',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(46,6,'212c0a9391fc4fde9be25eca648133ab','Direct Bilirubin','Direct Bilirubin Calculated','0.3','mg/dL',0.2999999999999999889,'mg/dL',NULL,NULL,'Neonate: 0.0-0.6, Adult: 0.0-0.3','Liver',0,1,'2025-04-01 17:30:01.860642',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(47,6,'212c0a9391fc4fde9be25eca648133ab','Indirect Bilirubin','Indirect Bilirubin Dual wavelength','0.5','mg/dL',0.5,'mg/dL',NULL,NULL,'Adult: 0.1-1.1, Neonate: 0.6-10.5','Liver',0,1,'2025-04-01 17:30:01.860643',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(48,6,'212c0a9391fc4fde9be25eca648133ab','Aspartate Aminotransferase','Aspartate Transaminase(AST/ SGOT)','25','U/L',25.0,'U/L',17.0,49.0,'17-49','Liver',0,1,'2025-04-01 17:30:01.860644',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(49,6,'212c0a9391fc4fde9be25eca648133ab','Alanine Aminotransferase','Alanine Transaminase(ALT/ SGPT)','35','U/L',35.0,'U/L',NULL,50.0,'< 50','Liver',0,1,'2025-04-01 17:30:01.860645',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(50,6,'212c0a9391fc4fde9be25eca648133ab','Alkaline Phosphatase','Alkaline Phosphatase','55','U/L',55.0,'U/L',38.0,126.0,'38-126','Liver',0,1,'2025-04-01 17:30:01.860646',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(51,6,'212c0a9391fc4fde9be25eca648133ab','Gamma-Glutamyl Transferase','Gamma-Glutamyl Transferase (GGT)','16','U/L',16.0,'U/L',15.0,73.0,'15-73','Liver',0,1,'2025-04-01 17:30:01.860647',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(52,6,'212c0a9391fc4fde9be25eca648133ab','Total Protein','Total Protein','7.0','g/dL',7.0,'g/dL',6.0,8.300000000000000711,'6.0-8.3','Liver',0,1,'2025-04-01 17:30:01.860648',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(53,6,'212c0a9391fc4fde9be25eca648133ab','Albumin','Albumin','4.1','g/dL',4.099999999999999644,'g/dL',3.5,5.0,'3.5-5.0','Liver',0,1,'2025-04-01 17:30:01.860649',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(54,6,'212c0a9391fc4fde9be25eca648133ab','Globulin','Globulin Calculated','2.9','g/dL',2.899999999999999912,'g/dL',2.299999999999999822,3.5,'2.3-3.5','Liver',0,1,'2025-04-01 17:30:01.860650',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(55,6,'212c0a9391fc4fde9be25eca648133ab','Albumin/Globulin Ratio','A/G ratio Calculated','1.4',NULL,1.399999999999999912,'-',0.8000000000000000444,2.0,'0.8-2.0','Liver',0,1,'2025-04-01 17:30:01.860651',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(56,6,'212c0a9391fc4fde9be25eca648133ab','Aspartate Aminotransferase/Alanine Aminotransferase Ratio','SGOT/SGPT- RATIO Calculated','0.7',NULL,0.6999999999999999556,'-',0.6999999999999999556,1.399999999999999912,'0.7-1.4','Liver',0,1,'2025-04-01 17:30:01.860652',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(57,6,'212c0a9391fc4fde9be25eca648133ab','Glycosylated Hemoglobin','Glycosylated Haemoglobin (HbA1c)','5.5','%',5.5,'%',NULL,5.700000000000000177,'< 5.7 Non Diabetic, 5.7-6.4 Pre-Diabetes, >= 6.5 Diabetes','Metabolic',0,1,'2025-04-01 17:30:01.860653',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(58,6,'212c0a9391fc4fde9be25eca648133ab','Mean Blood Glucose','Mean Blood Glucose','111','mg/dL',111.0,'mg/dL',NULL,NULL,'','Metabolic',0,1,'2025-04-01 17:30:01.860654',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(59,6,'212c0a9391fc4fde9be25eca648133ab','Urea','Serum Urea Urease','33','mg/dL',33.0,'mg/dL',19.0,43.0,'19-43 mg/dL','Kidney',0,1,'2025-04-01 17:30:01.860655',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(60,6,'212c0a9391fc4fde9be25eca648133ab','Blood Urea Nitrogen','Blood Urea Nitrogen (BUN)','15.4','mg/dL',15.40000000000000035,'mg/dL',6.0,20.0,'6-20 mg/dL','Kidney',0,1,'2025-04-01 17:30:01.860655',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(61,6,'212c0a9391fc4fde9be25eca648133ab','Creatinine','Creatinine Enzymatic','1.0','mg/dL',1.0,'mg/dL',0.660000000000000031,1.25,'0.66-1.25 mg/dL','Kidney',0,1,'2025-04-01 17:30:01.860656',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(62,6,'212c0a9391fc4fde9be25eca648133ab','BUN/Creatinine Ratio','BUN Creatinine Ratio','15.4','Ratio',15.40000000000000035,'Ratio',10.0,20.0,'10-20 Ratio','Kidney',0,1,'2025-04-01 17:30:01.860657',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(63,6,'212c0a9391fc4fde9be25eca648133ab','Calcium','Calcium Arsenazo Method','9.2','mg/dL',9.199999999999999289,'mg/dL',8.400000000000000355,10.19999999999999928,'8.4-10.2 mg/dL','Metabolic',0,1,'2025-04-01 17:30:01.860658',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(64,6,'212c0a9391fc4fde9be25eca648133ab','Uric Acid','Uric Acid Uricase','6.7','mg/dL',6.700000000000000177,'mg/dL',3.5,8.5,'3.5-8.5 mg/dL','Metabolic',0,1,'2025-04-01 17:30:01.860659',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(65,6,'212c0a9391fc4fde9be25eca648133ab','Total Cholesterol','Serum Total Cholesterol CHOD-POD','222','mg/dl',222.0,'mg/dL',NULL,200.0,'< 200 mg/dL','Lipid',1,1,'2025-04-01 17:30:01.860660',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(66,6,'212c0a9391fc4fde9be25eca648133ab','Triglycerides','Triglycerides GPO-POD','206','mg/dL',206.0,'mg/dL',NULL,150.0,'< 150 mg/dL','Lipid',1,1,'2025-04-01 17:30:01.860661',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(67,6,'212c0a9391fc4fde9be25eca648133ab','HDL Cholesterol','HDL Cholesterol Direct','30','mg/dL',30.0,'mg/dL',50.0,NULL,'> 50 mg/dL','Lipid',1,1,'2025-04-01 17:30:01.860662',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(68,6,'212c0a9391fc4fde9be25eca648133ab','Non-HDL Cholesterol','Non-HDL Cholesterol','192','mg/dL',192.0,'mg/dL',NULL,130.0,'< 130 mg/dL','Lipid',1,1,'2025-04-01 17:30:01.860662',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(69,6,'212c0a9391fc4fde9be25eca648133ab','LDL Cholesterol','LDL Cholesterol','151','mg/dL',151.0,'mg/dL',NULL,100.0,'< 100 mg/dL','Lipid',1,1,'2025-04-01 17:30:01.860663',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(70,6,'212c0a9391fc4fde9be25eca648133ab','VLDL Cholesterol','VLDL Cholesterol','41','mg/dL',41.0,'mg/dL',NULL,30.0,'< 30','Lipid',1,1,'2025-04-01 17:30:01.860664',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(71,6,'212c0a9391fc4fde9be25eca648133ab','Cholesterol/HDL Ratio','Cholesterol / HDL Ratio','7.4',NULL,7.400000000000000355,'-',3.299999999999999823,4.400000000000000356,'3.30-4.40','Lipid',1,1,'2025-04-01 17:30:01.860665',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(72,6,'212c0a9391fc4fde9be25eca648133ab','LDL/HDL Ratio','LDL:HDL RATIO','5',NULL,5.0,'-',0.5,3.0,'0.5-3.0','Lipid',1,1,'2025-04-01 17:30:01.860666',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(73,6,'212c0a9391fc4fde9be25eca648133ab','HDL/LDL Ratio','HDL/LDL RATIO','0.2',NULL,0.2000000000000000111,'-',0.4000000000000000222,NULL,'Ratio > 0.4','Lipid',1,1,'2025-04-01 17:30:01.860667',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(74,6,'212c0a9391fc4fde9be25eca648133ab','Thyroid Stimulating Hormone','Thyroid Stimulating Hormone (TSH)','2.570','¬µIU/mL',2.584999999999999965,'ŒºIU/mL',0.4000000000000000222,4.049000000000000377,'0.400-4.049 ŒºIU/mL','Thyroid',0,1,'2025-04-01 17:30:01.860668',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(75,6,'212c0a9391fc4fde9be25eca648133ab','Vitamin D','Vitamin D (25 OH Cholecalciferol)','64.1','ng/mL',64.09999999999999431,'ng/mL',NULL,20.0,'Deficient: < 20 Insufficient: 20-30 Sufficient: 30-100 Toxicity: > 100','Vitamin',0,1,'2025-04-01 17:30:01.860669',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(76,6,'212c0a9391fc4fde9be25eca648133ab','Red Blood Cell Count','RBC count','4.89','mill/cu.mm',4.889999999999999681,'million/mm3',NULL,NULL,'4.5-5.5 million/mm3','Blood',0,1,'2025-04-01 17:30:01.860669',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(77,6,'212c0a9391fc4fde9be25eca648133ab','Hemoglobin','Haemoglobin (Hb)','14.6','gm/dL',14.59999999999999965,'g/dL',13.0,17.0,'13.0-17.0 g/dL','Blood',0,1,'2025-04-01 17:30:01.860671',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(78,6,'212c0a9391fc4fde9be25eca648133ab','Hematocrit','Haematocrit(PCV)','43.5','%',43.5,'%',40.0,50.0,'40-50 %','Blood',0,1,'2025-04-01 17:30:01.860672',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(79,6,'212c0a9391fc4fde9be25eca648133ab','Mean Corpuscular Volume','Mean Corpuscular Volume (MCV)','88.9','fL',88.90000000000000569,'fL',83.0,101.0,'83-101 fL','Blood',0,1,'2025-04-01 17:30:01.860672',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(80,6,'212c0a9391fc4fde9be25eca648133ab','Mean Corpuscular Hemoglobin','Mean Corpuscular Haemoglobin(MCH)','29.8','pg',29.80000000000000071,'pg',27.0,32.0,'27-32 pg','Blood',0,1,'2025-04-01 17:30:01.860673',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(81,6,'212c0a9391fc4fde9be25eca648133ab','Mean Corpuscular Hemoglobin Concentration','Mean Corpuscular Haemoglobin Concentration (MCHC)','33.6','g/dL',33.60000000000000142,'g/dL',31.5,34.5,'31.5-34.5 g/dL','Blood',0,1,'2025-04-01 17:30:01.860674',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(82,6,'212c0a9391fc4fde9be25eca648133ab','Red Cell Distribution Width','Red cell distribution width (RDW)','13.2','%',13.19999999999999929,'%',11.59999999999999965,14.0,'11.6-14.0 %','Blood',0,1,'2025-04-01 17:30:01.860675',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(83,6,'212c0a9391fc4fde9be25eca648133ab','Total WBC count','Total WBC count - TC DC Impedance method','7540','cells/cu.mm',7540.0,'cells/cu.mm',4000.0,10000.0,'4000-10000','Blood',0,1,'2025-04-01 17:30:01.860676',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(84,6,'212c0a9391fc4fde9be25eca648133ab','Neutrophils','Neutrophils','57.4 %','%',57.39999999999999858,'%',40.0,80.0,'40-80','Blood',0,1,'2025-04-01 17:30:01.860677',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(85,6,'212c0a9391fc4fde9be25eca648133ab','Lymphocytes','Lymphocytes','28.1 %','%',28.10000000000000142,'%',20.0,40.0,'20-40','Blood',0,1,'2025-04-01 17:30:01.860678',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(86,6,'212c0a9391fc4fde9be25eca648133ab','Monocytes','Monocytes','7.8 %','%',7.799999999999999823,'%',2.0,10.0,'2-10','Blood',0,1,'2025-04-01 17:30:01.860679',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(87,6,'212c0a9391fc4fde9be25eca648133ab','Eosinophils','Eosinophils','6.3 %','%',6.299999999999999823,'%',1.0,6.0,'1-6','Blood',1,1,'2025-04-01 17:30:01.860679',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(88,6,'212c0a9391fc4fde9be25eca648133ab','Basophils','Basophils','0.4 %','%',0.4000000000000000222,'%',0.0,2.0,'0-2','Blood',0,1,'2025-04-01 17:30:01.860680',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(89,6,'212c0a9391fc4fde9be25eca648133ab','Absolute Neutrophil Count','Absolute Neutrophil Count Calculated','4328 / cu.mm','/ cu.mm',4328.0,'/cu.mm',2000.0,7000.0,'2000-7000','Blood',0,1,'2025-04-01 17:30:01.860681',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(90,6,'212c0a9391fc4fde9be25eca648133ab','Absolute Lymphocyte Count','Absolute Lymphocyte Count Calculated','2119 / cu.mm','/ cu.mm',2119.0,'/cu.mm',1000.0,3000.0,'1000-3000','Blood',0,1,'2025-04-01 17:30:01.860682',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(91,6,'212c0a9391fc4fde9be25eca648133ab','Absolute Monocyte Count','Absolute Monocyte Count Calculated','588 / cu.mm','/ cu.mm',588.0,'/cu.mm',200.0,1000.0,'200-1000','Blood',0,1,'2025-04-01 17:30:01.860683',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(92,6,'212c0a9391fc4fde9be25eca648133ab','Absolute Eosinophil Count','Absolute Eosinophil Count Calculated','475 / cu.mm','/ cu.mm',475.0,'/cu.mm',20.0,500.0,'20-500','Blood',0,1,'2025-04-01 17:30:01.860684',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(93,6,'212c0a9391fc4fde9be25eca648133ab','Absolute Basophil Count','Absolute Basophil Count Calculated','30 / cu.mm','/ cu.mm',30.0,'/cu.mm',0.0,100.0,'0-100','Blood',0,1,'2025-04-01 17:30:01.860685',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(94,6,'212c0a9391fc4fde9be25eca648133ab','Neutrophil Lymphocyte Ratio','Neutrophil Lymphocyte Ratio (NLR) Calculated','2.0 Ratio','Ratio',2.0,'Ratio',1.0,3.0,'1.0-3.0','Blood',0,1,'2025-04-01 17:30:01.860686',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(95,6,'212c0a9391fc4fde9be25eca648133ab','Platelet Count','Platelet count DC Impedance method','271','10^3/ul',271.0,'10^3/uL',NULL,NULL,'150-450 10^3/uL','Blood',0,1,'2025-04-01 17:30:01.860687',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(96,6,'212c0a9391fc4fde9be25eca648133ab','Platelet Hematocrit','Platelet hematocrit Calculated','0.288','%',0.2879999999999999783,'%',0.2000000000000000111,0.5,'0.20-0.50 %','Blood',0,1,'2025-04-01 17:30:01.860688',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(97,6,'212c0a9391fc4fde9be25eca648133ab','Mean Platelet Volume','Mean Platelet Volume (MPV) Calculated','10.6','fL',10.59999999999999965,'fL',7.0,13.0,'7-13 fL','Blood',0,1,'2025-04-01 17:30:01.860689',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(98,6,'212c0a9391fc4fde9be25eca648133ab','Erythrocyte Sedimentation Rate','Erythrocyte Sedimentation Rate Quantitative Capillary Photometry','5','mm/hr',5.0,'mm/hr',0.0,10.0,'0-10 mm/hr','Blood',0,1,'2025-04-01 17:30:01.860689',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(99,7,NULL,'Hemoglobin','Hemoglobin (HB)','14.9','g/dL',14.90000000000000035,'g/dL',13.0,17.0,'13.0 - 17.0','Blood',0,1,'2025-04-02 14:24:58.568258',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(100,7,NULL,'Glycosylated Hemoglobin','HbA1C (Glycosylated Haemoglobin)','5.5','%',5.5,'%',NULL,5.700000000000000177,'<5.7','Metabolic',0,1,'2025-04-02 14:24:58.568260',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(101,7,NULL,'Estimated Average Glucose','Estimated Average Glucose calculated.','111.15','mg/dL',111.1500000000000056,'mg/dL',NULL,NULL,'','Metabolic',0,1,'2025-04-02 14:24:58.568261',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(102,7,NULL,'Total Cholesterol','Total Cholesterol enzymatic CHOD-PAP','256','mg/dL',256.0,'mg/dL',NULL,200.0,'<200','Lipid',1,1,'2025-04-02 14:24:58.568262',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(103,7,NULL,'Triglycerides','Triglycerides Glycerol phosphate oxidase','391','mg/dL',391.0,'mg/dL',NULL,150.0,'<150','Lipid',1,1,'2025-04-02 14:24:58.568263',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(104,7,NULL,'HDL Cholesterol','HDL Cholesterol cholesterol oxidase and peroxidase','31','mg/dL',31.0,'mg/dL',40.0,NULL,'>40','Lipid',1,1,'2025-04-02 14:24:58.568264',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(105,7,NULL,'Non HDL Cholesterol','Non HDL Cholesterol Calculated','225','mg/dL',225.0,'mg/dL',NULL,130.0,'<130','Lipid',1,1,'2025-04-02 14:24:58.568265',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(106,7,NULL,'LDL Cholesterol','LDL Cholesterol Calculated','146.8','mg/dL',146.8000000000000113,'mg/dL',NULL,100.0,'<100','Lipid',1,1,'2025-04-02 14:24:58.568266',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(107,7,NULL,'VLDL Cholesterol','V.L.D.L Cholesterol Calculated','78.2','mg/dL',78.20000000000000284,'mg/dL',NULL,30.0,'< 30','Lipid',1,1,'2025-04-02 14:24:58.568266',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(108,7,NULL,'Non-HDL Cholesterol','Non-HDL','<80','mg/dl',80.0,'mg/dL',NULL,NULL,'','Lipid',0,1,'2025-04-02 14:24:58.568267',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(109,7,NULL,'Lipoprotein A','Lipoprotein a','>/= 50 mg/dl','mg/dl',50.0,'mg/dL',NULL,NULL,'','Lipid',1,1,'2025-04-02 14:24:58.568268',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(110,7,NULL,'Coronary Artery Calcium Score','Coronary Artery Calcium - CAC','> 300 AU','AU',300.0,'AU',NULL,NULL,'','Cardiovascular',1,1,'2025-04-02 14:24:58.568269',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(111,8,'212c0a9391fc4fde9be25eca648133ab','Glucose','FASTING BLOOD SUGAR(GLUCOSE)','95','mg/dL',95.0,'mg/dL',NULL,NULL,'','Metabolic',0,1,'2025-04-02 14:35:10.398980',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(112,8,'212c0a9391fc4fde9be25eca648133ab','Chloride','CHLORIDE',NULL,NULL,0.0,'mEq/L',NULL,NULL,'','Electrolyte',0,1,'2025-04-02 14:35:10.398985',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(113,8,'212c0a9391fc4fde9be25eca648133ab','Sodium','SODIUM',NULL,NULL,0.0,'mEq/L',NULL,NULL,'','Electrolyte',0,1,'2025-04-02 14:35:10.398986',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(115,8,'212c0a9391fc4fde9be25eca648133ab','Vitamin D','25-OH VITAMIN D (TOTAL)','40.45','ng/mL',40.45000000000000285,'ng/mL',NULL,20.0,'DEFICIENCY : <20 ng/ml || INSUFFICIENCY : 20-<30 ng/ml SUFFICIENCY : 30-100 ng/ml || TOXICITY : >100 ng/ml','Vitamin',0,1,'2025-04-02 14:35:10.398988',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(116,8,'212c0a9391fc4fde9be25eca648133ab','Vitamin B12','VITAMIN B-12','434','pg/mL',434.0,'pg/mL',211.0,911.0,'Normal : 211 - 911 pg/ml','Vitamin',0,1,'2025-04-02 14:35:10.398988',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(117,8,'212c0a9391fc4fde9be25eca648133ab','Apolipoprotein A1','APOLIPOPROTEIN - A1 (APO-A1)','110','mg/dL',119.0,'mg/dL',NULL,NULL,'Male : 86 - 152 Female : 94 - 162','Lipid',0,1,'2025-04-02 14:35:10.398989',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(118,8,'212c0a9391fc4fde9be25eca648133ab','Apolipoprotein B','APOLIPOPROTEIN - B (APO-B)','134','mg/dL',134.0,'mg/dL',NULL,NULL,'Male : 56 - 145 Female : 53 - 138','Lipid',0,1,'2025-04-02 14:35:10.398990',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(119,8,'212c0a9391fc4fde9be25eca648133ab','Apolipoprotein B/A1 Ratio','APO B / APO A1 RATIO (APO B/A1)','1.2','Ratio',1.129999999999999893,'ratio',NULL,NULL,'Male : 0.40 - 1.26 Female : 0.38 - 1.14','Lipid',0,1,'2025-04-02 14:35:10.398991',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(120,8,'212c0a9391fc4fde9be25eca648133ab','High Sensitivity C-Reactive Protein','HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP)','0.8','mg/L',0.8000000000000000444,'mg/L',NULL,1.0,'< 1.00 - Low Risk 1.00 - 3.00 - Average Risk >3.00 - 10.00 - High Risk > 10.00 - Possibly due to Non -Cardiac Inflammation','Cardiovascular',0,1,'2025-04-02 14:35:10.398991',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(121,8,'212c0a9391fc4fde9be25eca648133ab','Lipoprotein(a)','Lipoprotein (a) [Lp(a)]','14.4','mg/dL',14.40000000000000035,'mg/dL',NULL,30.0,'Adults : < 30.0 mg/dl','Lipid',0,1,'2025-04-02 14:35:10.398992',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(122,8,'212c0a9391fc4fde9be25eca648133ab','Iron','IRON','68.69','¬µg/dL',67.34499999999999887,'Œºg/dL',NULL,NULL,'Male : 65 - 175 Female : 50 - 170','Blood',0,1,'2025-04-02 14:35:10.398993',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(123,8,'212c0a9391fc4fde9be25eca648133ab','Total iron binding capacity','TOTAL IRON BINDING CAPACITY (TIBC)','377.69','¬µg/dL',377.6899999999999978,'Œºg/dL',NULL,NULL,'Male: 225 - 535 ¬µg/dl Female: 215 - 535 ¬µg/dl','Blood',0,1,'2025-04-02 14:35:10.398993',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(124,8,'212c0a9391fc4fde9be25eca648133ab','Transferrin saturation','% TRANSFERRIN SATURATION','18.19','%',18.19000000000000127,'%',13.0,45.0,'13 - 45','Blood',0,1,'2025-04-02 14:35:10.398994',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(125,8,'212c0a9391fc4fde9be25eca648133ab','Unsaturated iron binding capacity','UNSAT.IRON-BINDING CAPACITY(UIBC)','309','¬µg/dL',309.0,'Œºg/dL',162.0,368.0,'162 - 368','Blood',0,1,'2025-04-02 14:35:10.398995',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(126,8,'212c0a9391fc4fde9be25eca648133ab','Alkaline Phosphatase','ALKALINE PHOSPHATASE','88.09','U/L',88.09000000000000341,'U/L',45.0,129.0,'45-129 U/L','Liver',0,1,'2025-04-02 14:35:10.398995',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(127,8,'212c0a9391fc4fde9be25eca648133ab','Total Bilirubin','BILIRUBIN - TOTAL','0.48','mg/dL',0.4799999999999999823,'mg/dL',0.2999999999999999889,1.199999999999999956,'0.3-1.2 mg/dL','Liver',0,1,'2025-04-02 14:35:10.398996',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(128,8,'212c0a9391fc4fde9be25eca648133ab','Direct Bilirubin','BILIRUBIN -DIRECT','0.1','mg/dL',0.1000000000000000055,'mg/dL',NULL,0.2999999999999999889,'< 0.3 mg/dL','Liver',0,1,'2025-04-02 14:35:10.398998',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(129,8,'212c0a9391fc4fde9be25eca648133ab','Indirect Bilirubin','BILIRUBIN (INDIRECT)','0.38','mg/dL',0.3800000000000000044,'mg/dL',0.0,0.9000000000000000222,'0-0.9 mg/dL','Liver',0,1,'2025-04-02 14:35:10.398998',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(130,8,'212c0a9391fc4fde9be25eca648133ab','Gamma-glutamyl Transferase','GAMMA GLUTAMYL TRANSFERASE (GGT)','22.4','U/L',22.39999999999999857,'U/L',NULL,55.0,'< 55 U/L','Liver',0,1,'2025-04-02 14:35:10.398999',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(131,8,'212c0a9391fc4fde9be25eca648133ab','AST/ALT Ratio','SGOT / SGPT RATIO','0.78','Ratio',0.7800000000000000266,'Ratio',NULL,2.0,'< 2 Ratio','Liver',0,1,'2025-04-02 14:35:10.399000',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(132,8,'212c0a9391fc4fde9be25eca648133ab','Aspartate Aminotransferase','ASPARTATE AMINOTRANSFERASE (SGOT )','33.3','U/L',33.29999999999999715,'U/L',NULL,35.0,'< 35 U/L','Liver',0,1,'2025-04-02 14:35:10.399000',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(133,8,'212c0a9391fc4fde9be25eca648133ab','Alanine Aminotransferase','ALANINE TRANSAMINASE (SGPT)','42.6','U/L',42.60000000000000142,'U/L',NULL,45.0,'< 45 U/L','Liver',0,1,'2025-04-02 14:35:10.399001',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(134,8,'212c0a9391fc4fde9be25eca648133ab','Total Protein','PROTEIN - TOTAL','7.73','gm/dL',7.730000000000000426,'gm/dL',5.700000000000000177,8.199999999999999289,'5.7-8.2 gm/dL','Metabolic',0,1,'2025-04-02 14:35:10.399002',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(135,8,'212c0a9391fc4fde9be25eca648133ab','Albumin','ALBUMIN - SERUM','4.77','gm/dL',4.769999999999999574,'gm/dL',3.200000000000000177,4.799999999999999823,'3.2-4.8 gm/dL','Metabolic',0,1,'2025-04-02 14:35:10.399002',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(136,8,'212c0a9391fc4fde9be25eca648133ab','Globulin','SERUM GLOBULIN','2.96','gm/dL',2.959999999999999965,'gm/dL',2.5,3.399999999999999912,'2.5-3.4 gm/dL','Metabolic',0,1,'2025-04-02 14:35:10.399003',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(137,8,'212c0a9391fc4fde9be25eca648133ab','Albumin/Globulin Ratio','SERUM ALB/GLOBULIN RATIO','1.61','Ratio',1.610000000000000097,'Ratio',0.9000000000000000222,2.0,'0.9 - 2 Ratio','Metabolic',0,1,'2025-04-02 14:35:10.399004',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(138,8,'212c0a9391fc4fde9be25eca648133ab','Blood Urea Nitrogen','BLOOD UREA NITROGEN (BUN)','15.2 - 20.07 mg/dL','mg/dL',18.63500000000000157,'mg/dL',7.94000000000000039,20.07000000000000028,'7.94 - 20.07 mg/dL','Kidney',0,1,'2025-04-02 14:35:10.399004',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(139,8,'212c0a9391fc4fde9be25eca648133ab','Urea/Creatinine Ratio','UREA / SR.CREATININE RATIO','< 52 Ratio','Ratio',36.54999999999999715,'Ratio',NULL,52.0,'< 52 Ratio','Kidney',0,1,'2025-04-02 14:35:10.399005',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(140,8,'212c0a9391fc4fde9be25eca648133ab','Creatinine','CREATININE - SERUM','0.72-1.18 mg/dL','mg/dL',1.0,'mg/dL',0.7199999999999999734,1.179999999999999938,'0.72-1.18 mg/dL','Kidney',0,1,'2025-04-02 14:35:10.399006',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(141,8,'212c0a9391fc4fde9be25eca648133ab','BUN/Creatinine Ratio','BUN / SR.CREATININE RATIO','9:1-23:1 Ratio','Ratio',16.08500000000000085,'Ratio',NULL,NULL,'9:1-23:1 Ratio','Kidney',0,1,'2025-04-02 14:35:10.399006',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(142,8,'212c0a9391fc4fde9be25eca648133ab','Calcium','CALCIUM','8.8-10.6 mg/dL','mg/dL',9.69999999999999928,'mg/dL',8.800000000000000711,10.59999999999999965,'8.8-10.6 mg/dL','Electrolyte',0,1,'2025-04-02 14:35:10.399007',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(143,8,'212c0a9391fc4fde9be25eca648133ab','Uric Acid','URIC ACID','4.2 - 7.3 mg/dL','mg/dL',5.980000000000000426,'mg/dL',4.200000000000000177,7.299999999999999823,'4.2 - 7.3 mg/dL','Metabolic',0,1,'2025-04-02 14:35:10.399008',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(144,8,'212c0a9391fc4fde9be25eca648133ab','Triiodothyronine','TOTAL TRIIODOTHYRONINE (T3)','111','ng/dL',111.0,'ng/dL',80.0,200.0,'80-200 ng/dL','Thyroid',0,1,'2025-04-02 14:35:10.399008',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(145,8,'212c0a9391fc4fde9be25eca648133ab','Thyroxine','TOTAL THYROXINE (T4)','8.54','¬µg/dL',8.539999999999999147,'Œºg/dL',4.799999999999999823,12.69999999999999929,'4.8-12.7 Œºg/dL','Thyroid',0,1,'2025-04-02 14:35:10.399009',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(146,8,'212c0a9391fc4fde9be25eca648133ab','Thyroid Stimulating Hormone','TSH - ULTRASENSITIVE','3.02','¬µIU/mL',3.020000000000000017,'ŒºIU/mL',0.5400000000000000355,5.299999999999999823,'0.54-5.30 ŒºIU/mL','Thyroid',0,1,'2025-04-02 14:35:10.399009',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(147,8,'212c0a9391fc4fde9be25eca648133ab','Estimated Glomerular Filtration Rate','EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED','114','mL/min/1.73 m2',114.0,'mL/min/1.73m^2',NULL,NULL,'>= 90: Normal, 60 - 89: Mild Decrease, 45 - 59: Mild to Moderate Decrease, 30 - 44: Moderate to Severe Decrease, 15 - 29: Severe Decrease','Kidney',0,1,'2025-04-02 14:35:10.399010',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(148,8,'212c0a9391fc4fde9be25eca648133ab','Total Cholesterol','TOTAL CHOLESTEROL','249','mg/dL',249.0,'mg/dL',NULL,200.0,'< 200 mg/dL','Lipid',1,1,'2025-04-02 14:35:10.399011',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(149,8,'212c0a9391fc4fde9be25eca648133ab','HDL Cholesterol','HDL CHOLESTEROL - DIRECT','37','mg/dL',37.0,'mg/dL',40.0,60.0,'40-60 mg/dL','Lipid',1,1,'2025-04-02 14:35:10.399012',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(150,8,'212c0a9391fc4fde9be25eca648133ab','HDL/LDL Ratio','HDL / LDL RATIO','0.21','Ratio',0.2099999999999999923,'Ratio',0.4000000000000000222,NULL,'> 0.40 Ratio','Lipid',1,1,'2025-04-02 14:35:10.399012',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(151,8,'212c0a9391fc4fde9be25eca648133ab','LDL Cholesterol','LDL CHOLESTEROL - DIRECT','177','mg/dL',177.0,'mg/dL',NULL,100.0,'< 100 mg/dL','Lipid',1,1,'2025-04-02 14:35:10.399013',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(152,8,'212c0a9391fc4fde9be25eca648133ab','Triglycerides','TRIGLYCERIDES','232','mg/dL',232.0,'mg/dL',NULL,150.0,'< 150 mg/dL','Lipid',1,1,'2025-04-02 14:35:10.399013',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(153,8,'212c0a9391fc4fde9be25eca648133ab','Total Cholesterol/HDL Ratio','TC/ HDL CHOLESTEROL RATIO','6.6','Ratio',6.599999999999999645,'Ratio',3.0,5.0,'3 - 5 Ratio','Lipid',1,1,'2025-04-02 14:35:10.399014',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(154,8,'212c0a9391fc4fde9be25eca648133ab','LDL/HDL Ratio','LDL / HDL RATIO','4.7','Ratio',4.700000000000000177,'Ratio',1.5,3.5,'1.5-3.5 Ratio','Lipid',1,1,'2025-04-02 14:35:10.399015',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(155,8,'212c0a9391fc4fde9be25eca648133ab','VLDL Cholesterol','VLDL CHOLESTEROL','46.46','mg/dL',46.46000000000000085,'mg/dL',5.0,40.0,'5 - 40 mg/dL','Lipid',1,1,'2025-04-02 14:35:10.399015',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(156,8,'212c0a9391fc4fde9be25eca648133ab','Non-HDL Cholesterol','NON-HDL CHOLESTEROL','211.1','mg/dL',211.0999999999999944,'mg/dL',NULL,160.0,'< 160 mg/dL','Lipid',1,1,'2025-04-02 14:35:10.399016',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(157,8,'212c0a9391fc4fde9be25eca648133ab','Triglyceride/HDL Ratio','TRIG / HDL RATIO','6.21','Ratio',6.209999999999999965,'Ratio',NULL,3.120000000000000106,'< 3.12 Ratio','Lipid',1,1,'2025-04-02 14:35:10.399017',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(158,8,'212c0a9391fc4fde9be25eca648133ab','Hemoglobin A1c','HbA1c','5.1','%',5.099999999999999645,'%',NULL,NULL,'Below 5.7%: Normal, 5.7% - 6.4%: Prediabetic, >=6.5%: Diabetic','Metabolic',0,1,'2025-04-02 14:35:10.399018',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(159,8,'212c0a9391fc4fde9be25eca648133ab','Average Blood Glucose','AVERAGE BLOOD GLUCOSE (ABG)','100 CALCULATED','mg/dL',105.0,'mg/dL',180.0,NULL,'90 - 120 mg/dl: Good Control, 121 - 150 mg/dl: Fair Control, 151 - 180 mg/dl: Unsatisfactory Control, > 180 mg/dl: Poor Control','Metabolic',1,1,'2025-04-02 14:35:10.399018',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(160,8,'212c0a9391fc4fde9be25eca648133ab','Total Leucocytes Count','TOTAL LEUCOCYTES COUNT (WBC)','9.86','X 10¬≥ / ¬µL',9.85999999999999944,'10^3/¬µL',4.0,10.0,'4.0 - 10.0','Blood',0,1,'2025-04-02 14:35:10.399019',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(161,8,'212c0a9391fc4fde9be25eca648133ab','Neutrophils Percentage','NEUTROPHILS','61.5','%',61.5,'%',40.0,80.0,'40-80','Blood',0,1,'2025-04-02 14:35:10.399020',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(162,8,'212c0a9391fc4fde9be25eca648133ab','Lymphocytes Percentage','LYMPHOCYTE','26.6','%',26.60000000000000142,'%',20.0,40.0,'20-40','Blood',0,1,'2025-04-02 14:35:10.399020',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(163,8,'212c0a9391fc4fde9be25eca648133ab','Monocytes Percentage','MONOCYTES','3.5','%',3.5,'%',2.0,10.0,'2-10','Blood',0,1,'2025-04-02 14:35:10.399021',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(164,8,'212c0a9391fc4fde9be25eca648133ab','Eosinophils Percentage','EOSINOPHILS','7.6','%',7.599999999999999645,'%',1.0,6.0,'1-6','Blood',1,1,'2025-04-02 14:35:10.399022',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(165,8,'212c0a9391fc4fde9be25eca648133ab','Basophils Percentage','BASOPHILS','0.5','%',0.5,'%',0.0,2.0,'0-2','Blood',0,1,'2025-04-02 14:35:10.399022',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(166,8,'212c0a9391fc4fde9be25eca648133ab','Immature Granulocytes Percentage','IMMATURE GRANULOCYTE PERCENTAGE(IG%)','0.3','%',0.2999999999999999889,'%',0.0,0.5,'0-0.5','Blood',0,1,'2025-04-02 14:35:10.399023',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(167,8,'212c0a9391fc4fde9be25eca648133ab','Neutrophils Absolute Count','NEUTROPHILS - ABSOLUTE COUNT','6.06','X 10¬≥ / ¬µL',6.05999999999999961,'10^3/¬µL',2.0,7.0,'2.0-7.0','Blood',0,1,'2025-04-02 14:35:10.399024',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(168,8,'212c0a9391fc4fde9be25eca648133ab','Lymphocytes Absolute Count','LYMPHOCYTES - ABSOLUTE COUNT','2.62','X 10¬≥ / ¬µL',2.620000000000000106,'10^3/¬µL',1.0,3.0,'1.0-3.0','Blood',0,1,'2025-04-02 14:35:10.399024',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(169,8,'212c0a9391fc4fde9be25eca648133ab','Monocytes Absolute Count','MONOCYTES - ABSOLUTE COUNT','0.35','X 10¬≥ / ¬µL',0.3499999999999999778,'10^3/¬µL',0.2000000000000000111,1.0,'0.2 - 1.0','Blood',0,1,'2025-04-02 14:35:10.399025',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(170,8,'212c0a9391fc4fde9be25eca648133ab','Basophils Absolute Count','BASOPHILS - ABSOLUTE COUNT','0.05','X 10¬≥ / ¬µL',0.05000000000000000277,'10^3/¬µL',0.02000000000000000041,0.1000000000000000055,'0.02 - 0.1','Blood',0,1,'2025-04-02 14:35:10.399026',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(171,8,'212c0a9391fc4fde9be25eca648133ab','Eosinophils Absolute Count','EOSINOPHILS - ABSOLUTE COUNT','0.75','X 10¬≥ / ¬µL',0.75,'10^3/¬µL',0.02000000000000000041,0.5,'0.02 - 0.5','Blood',1,1,'2025-04-02 14:35:10.399026',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(172,8,'212c0a9391fc4fde9be25eca648133ab','Immature Granulocytes Absolute Count','IMMATURE GRANULOCYTES(IG)','0.03','X 10¬≥ / ¬µL',0.02999999999999999889,'10^3/¬µL',0.0,0.2999999999999999889,'0-0.3','Blood',0,1,'2025-04-02 14:35:10.399027',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(173,8,'212c0a9391fc4fde9be25eca648133ab','Total RBC Count','TOTAL RBC','5.42','X 10^6/¬µL',5.419999999999999929,'10^6/¬µL',4.5,5.5,'4.5-5.5','Blood',0,1,'2025-04-02 14:35:10.399028',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(174,8,'212c0a9391fc4fde9be25eca648133ab','Nucleated RBC Percentage','NUCLEATED RED BLOOD CELLS','0.01','%',0.0100000000000000002,'%',0.0,5.0,'0.0-5.0','Blood',0,1,'2025-04-02 14:35:10.399028',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(175,8,'212c0a9391fc4fde9be25eca648133ab','Hemoglobin','HEMOGLOBIN','15.9','g/dL',15.90000000000000035,'g/dL',13.0,17.0,'13.0-17.0','Blood',0,1,'2025-04-02 14:35:10.399029',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(176,8,'212c0a9391fc4fde9be25eca648133ab','Hematocrit','HEMATOCRIT(PCV)','48','%',48.0,'%',40.0,50.0,'40.0-50.0','Blood',0,1,'2025-04-02 14:35:10.399030',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(177,8,'212c0a9391fc4fde9be25eca648133ab','Mean Corpuscular Volume','MEAN CORPUSCULAR VOLUME(MCV)','88.6','fL',88.59999999999999431,'fL',83.0,101.0,'83.0-101.0','Blood',0,1,'2025-04-02 14:35:10.399030',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(178,8,'212c0a9391fc4fde9be25eca648133ab','Mean Corpuscular Hemoglobin','MEAN CORPUSCULAR HEMOGLOBIN(MCH)','29.3','pq',29.30000000000000071,'pg',27.0,32.0,'27.0-32.0','Blood',0,1,'2025-04-02 14:35:10.399031',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(179,8,'212c0a9391fc4fde9be25eca648133ab','Mean Corpuscular Hemoglobin Concentration','MEAN CORP.HEMO.CONC(MCHC)','33.1','g/dL',33.10000000000000142,'g/dL',31.5,34.5,'31.5-34.5','Blood',0,1,'2025-04-02 14:35:10.399031',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(180,8,'212c0a9391fc4fde9be25eca648133ab','Red Cell Distribution Width SD','RED CELL DISTRIBUTION WIDTH - SD(RDW-SD)','41.9','fL',41.89999999999999858,'fL',39.0,46.0,'39-46','Blood',0,1,'2025-04-02 14:35:10.399032',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(181,8,'212c0a9391fc4fde9be25eca648133ab','Red Cell Distribution Width CV','RED CELL DISTRIBUTION WIDTH (RDW-CV)','12.9','%',12.90000000000000035,'%',11.59999999999999965,14.0,'11.6-14','Blood',0,1,'2025-04-02 14:35:10.399033',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(182,8,'212c0a9391fc4fde9be25eca648133ab','Platelet Distribution Width','PLATELET DISTRIBUTION WIDTH(PDW)','12.3','fL',12.30000000000000071,'fL',9.59999999999999965,15.19999999999999929,'9.6-15.2','Blood',0,1,'2025-04-02 14:35:10.399033',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(183,8,'212c0a9391fc4fde9be25eca648133ab','Mean Platelet Volume','MEAN PLATELET VOLUME(MPV)','10.4','fL',10.40000000000000035,'fL',6.5,12.0,'6.5-12','Blood',0,1,'2025-04-02 14:35:10.399034',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(184,8,'212c0a9391fc4fde9be25eca648133ab','Platelet Count','PLATELET COUNT','320','X 10¬≥ / ¬µL',320.0,'10^3/¬µL',150.0,410.0,'150-410','Blood',0,1,'2025-04-02 14:35:10.399035',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(185,8,'212c0a9391fc4fde9be25eca648133ab','Platelet to Large Cell Ratio','PLATELET TO LARGE CELL RATIO(PLCR)','28.1','%',28.10000000000000142,'%',19.69999999999999929,42.39999999999999858,'19.7-42.4','Blood',0,1,'2025-04-02 14:35:10.399035',0,NULL,NULL,NULL);
INSERT INTO biomarkers VALUES(186,8,'212c0a9391fc4fde9be25eca648133ab','URINE05 Aug 2023 13','URINE05 Aug 2023 13','3405','Aug',3405.0,'Aug',NULL,NULL,replace('2023 12:3505 Aug 2023 08:13 :\n:\n:\n:Sample Collected on (SCT','\n',char(10)),'Other',0,1,'2025-04-02 14:35:10.399036',0,NULL,NULL,NULL);
CREATE TABLE alembic_version (
	version_num VARCHAR(32) NOT NULL, 
	CONSTRAINT alembic_version_pkc PRIMARY KEY (version_num)
);
INSERT INTO alembic_version VALUES('c1d2e3f4g5h6');
DELETE FROM sqlite_sequence;
CREATE UNIQUE INDEX ix_biomarker_dictionary_standard_name ON biomarker_dictionary (standard_name);
CREATE INDEX ix_biomarker_dictionary_id ON biomarker_dictionary (id);
CREATE INDEX ix_profiles_name ON profiles (name);
CREATE INDEX ix_profiles_id ON profiles (id);
CREATE INDEX ix_profiles_patient_id ON profiles (patient_id);
CREATE INDEX ix_pdfs_id ON pdfs (id);
CREATE UNIQUE INDEX ix_pdfs_file_id ON pdfs (file_id);
CREATE INDEX ix_biomarkers_name ON biomarkers (name);
CREATE INDEX ix_biomarkers_id ON biomarkers (id);
CREATE INDEX ix_profiles_user_id ON profiles (user_id);
COMMIT;
